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Abstract
The prevalence of allergic airway diseases such as asthma and rhinitis has increased dramatically to epidemic
proportions worldwide. Besides air pollution from industry derived emissions and motor vehicles, the rising trend
can only be explained by gross changes in the environments where we live. The world economy has been
transformed over the last 25 years with developing countries being at the core of these changes. Around the
planet, in both developed and developing countries, environments are undergoing profound changes. Many of
these changes are considered to have negative effects on respiratory health and to enhance the frequency and
severity of respiratory diseases such as asthma in the general population.
Increased concentrations of greenhouse gases, and especially carbon dioxide (CO2), in the atmosphere have already
warmed the planet substantially, causing more severe and prolonged heat waves, variability in temperature,
increased air pollution, forest fires, droughts, and floods – all of which can put the respiratory health of the public
at risk. These changes in climate and air quality have a measurable impact not only on the morbidity but also the
mortality of patients with asthma and other respiratory diseases. The massive increase in emissions of air pollutants
due to economic and industrial growth in the last century has made air quality an environmental problem of the
first order in a large number of regions of the world. A body of evidence suggests that major changes to our world
are occurring and involve the atmosphere and its associated climate. These changes, including global warming
induced by human activity, have an impact on the biosphere, biodiversity, and the human environment. Mitigating
this huge health impact and reversing the effects of these changes are major challenges.
This statement of the World Allergy Organization (WAO) raises the importance of this health hazard and highlights
(Continued on next page)
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the facts on climate-related health impacts, including: deaths and acute morbidity due to heat waves and extreme
meteorological events; increased frequency of acute cardio-respiratory events due to higher concentrations of ground
level ozone; changes in the frequency of respiratory diseases due to trans-boundary particle pollution; altered spatial
and temporal distribution of allergens (pollens, molds, and mites); and some infectious disease vectors. According to
this report, these impacts will not only affect those with current asthma but also increase the incidence and prevalence
of allergic respiratory conditions and of asthma. The effects of climate change on respiratory allergy are still not
well defined, and more studies addressing this topic are needed. Global warming is expected to affect the start,
duration, and intensity of the pollen season on the one hand, and the rate of asthma exacerbations due to air
pollution, respiratory infections, and/or cold air inhalation, and other conditions on the other hand.

Introduction
There is a fairly wide body of evidence to show that the
temperature of the planet Earth is increasing, as confirmed by warming of the oceans, rising sea levels, melting
of glaciers, shrinking sea ice in both Polar Regions, and diminished snow cover in the Northern Hemisphere during
the winter months. Most of the observed increase in
global average temperatures since the mid-twentieth
century is very likely due to the observed increase in
anthropogenic greenhouse gas concentrations. Moreover, changes are also occurring in the amount, intensity, frequency, and type of precipitation as well as the
increase of extreme weather events such as heat waves,
droughts, thunderstorms, floods, and hurricanes.
The major changes to our world involve the atmosphere
and its associated climate, including global warming induced by human activity, and are causing an impact on
the biosphere, biodiversity, and the human environment.
Observational evidence indicates that recent regional
changes in climate, particularly increases in temperature,
have already affected a diverse set of physical and biological systems in many parts of the world. A rapid increase has been observed in the number of hot days and
severe meteorological events witnessed across the globe.
Sea levels have also started to rise as an effect of a regression of the polar ice packs coupled with a decrease in pH
due to the effects of increasing carbon dioxide (CO2) on
our oceans. These events have led to water deprivation in
certain areas, often associated with water degradation,
which potentially could result in population migration and
the effects on health that result from mass population
movement.
Climate affects local and national food supplies, air and
water quality, weather, economics, and many other critical
health determinants. Thus, climate change represents a
massive threat to global health that could affect many disease factors in the twenty-first century. Among others, climate change influences the development of asthma and
allergic respiratory diseases and influences pollen and
mold productions that induce allergic manifestations.
There is also a link between climate change and air

pollution; an individual's response to air pollution depends
on the source and components of the pollution as well as
on climatic agents. Some air pollution-related episodes of
rhinitis and asthma exacerbation are due to climatic factors that favor the accumulation of air pollutants, such as
ozone, at ground level.
Migration studies provide useful information on the role
of environmental factors, including climate changes, in
the development of atopy and asthma. Migrants need to
be aware of the potential for developing allergies and/or
asthma with the change in habitat to an area of increased
prevalence of allergies [1]. Such migrations are not limited
to human migration but also of plant migrations to regions that previously did not have such plants in their environments [2]. Strategies for primary prevention in high
risk atopic individuals and secondary prevention guidelines should be developed for populations in developing
countries as well as immigrants from such countries who
move to atopy-prevalent developed countries. In recent
years such guidelines have been initiated by the World
Allergy Organization such as the GLAD-P [3].
Global warming affects the onset, duration, and intensity of the pollen season as well as the allergenicity of the
pollen. Studies on plant responses to elevated atmospheric
levels of CO2 indicate that plants exhibit enhanced photosynthesis and reproductive effects and produce more
pollen. Moreover, the plants flower earlier in urban areas
than in corresponding rural areas with earlier pollination
of about 2–4 days. The key determinants of greenhouse
gas emissions are energy production, transportation, agriculture, and food production and waste management;
attempts at mitigating climate change will need to address
each of these.
Current projections suggest that the world population
will rise to 9 billion by 2050. Regarding urbanization,
there are 20 cities expected to be populated by more
than 10 million inhabitants by the year 2015, and two
thirds of mankind are expected to live in a megalopolis
by 2020. Moreover, in the last 50 years 50 % of pluvial
forests on the planet have been destroyed, and each year
13 million hectares of forest are being destroyed or
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deteriorated. Food cultivation on wasted areas of tropical
pluvial forests determined about 35 % of deforestation in
countries in South America, 70 % in Africa, and 50 % in
Asia. While there is some uncertainty about predicting
future meteorological trends, and whatever interventions
may be put in place to ameliorate climate change, it is
still likely that the world will experience more hot days,
fewer frost days, and more periods of heavy rain and
consequent flooding. Paradoxically, it is likely that there
will be more periods of drought. A huge increase in CO2
concentrations during the last two decades has been experienced; it is important to consider that after CO2
emissions are reduced and atmospheric concentrations
stabilize, surface air temperature continues to rise slowly
for a century or more.
The outdoor environment is complex with interaction
between pollutants, both natural and manmade, and
weather. Although diesel particles and combustion products are not directly influenced by climate change, a discussion is included in this review because of this interaction.
The indoor environment is also directly influenced by the
outdoor environment. Due to this relationship, the effects
of indoor humidity and dampness are included in this
review. Sources of fungi are difficult to pinpoint with
some fungal species found both indoors and outdoors.
Furthermore, indoor fungal spores may be derived from
outdoor sources. Thus, the discussion of fungal allergens in
this review includes both indoor and outdoor influences.
Finally, there are discussions related to allergy and
asthma in the tropics, human migration, air filtration, violent conflict and economical aspects of climate change
that may not appear germane to a review of the effects of
climate change on allergic respiratory disease. The complexity of climate change on human life will likely make
these issues relevant. It is difficult to comment on the effects of climate change on allergic respiratory disease in
the tropics as there are limited data on the prevalence of
allergy and asthma in these highly populated areas. A discussion is included as it is expected that the change in
weather patterns will impact the tropics. Migration of
populations is likely to be impacted in multiple ways when
weather and rainfall change and migration changes the environmental effects of allergy. Air filtration is related to
the indoor environment but as with mold and dampness
the outside weather ultimately influences indoor allergen
exposure. Conflict, competition for resources and economics all indirectly effect healthcare but are particularly
important for diseases dependent on the environment.
Thus, all of these topics are indirectly related to climate
change and allergy and asthma.
As a consequence of the increased evidence of the link
between climate change and asthma and allergies, it is
important to focus on the underlying factors and bring
them together in a documented version, such as this
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global report of the World Allergy Organization (WAO).
Experts from different regions of the world have written
important sections in this document on the various aspects of interaction between meteorological factors, air
pollution, climate change, and human health. The contributions of these experts are appreciated. Their names
and section contributions are listed in Table 1.
Allergic respiratory diseases and asthma are a result of
environmental and immunologic interaction. Climate
change is modifying allergy and asthma in both predictable and unpredictable ways. Weather influences human
behavior and botanical allergen production. The result is
complex with many variables. This review summarizes
these variations and hopefully will aid in the response to
climate change.
Table 1 Section authors
Air Pollution Episodes
Isabella Annesi-Maesano (Section Leader), Tari Haahtela, Stephen T Holgate,
Juan José Sienra-Monge, Hasan Bayram, Gennaro D’Amato
Thunderstorm-related Asthma
Gennaro D’Amato (Section Leader), Lorenzo Cecchi, Nelson Rosário, Guy
Marks, Isabella Annesi-Maesano
Sandstorm
Saleh Al-Muhsen (Section Leader), Mona Al-Ahmad, Rabih Halwani,
Basam Mahboub, Fatma Al-Enezi, Hasan Bayram
Climate Change and Respiratory Allergy
Gennaro D’Amato (Section Leader), Lorenzo Cecchi, Isabella AnnesiMaesano, Karl Christian Bergmann
Pollen Allergy and Meteorological Factors
Lorenzo Cecchi (Section Leader), Jeroen TM Buters, Jae-Won Oh, Ignacio
Ansotegui, Carlos Nunes, Gennaro D’Amato
Molds, Rain, Humidity, Dampness
Jeroen Douwes (Section Leader), Maximiliano Gomez, Jay Portnoy
Allergy and Asthma in the Tropics
Carlos E Baena-Cagnani (Section Leader), Dennis Ledford, Ruby Pawankar,
Mario Sánchez-Borges, Elopy Sibanda
Migration and Urbanization
Nelson Rosário (Section Leader), Menachem Rottem
The Role of Air Filtration as an Environmental Control Measure for
Allergic Respiratory Disease
Gennaro D’Amato (Section Leader), Carolina Vitale, Maria D’Amato
Cold Weather
Todor A. Popov (Section Leader), Louis-Philippe Boulet, Paola Michelozzi
Wildfires and Asthma
Isabella Annesi-Maesano (Section Leader), Sarah Elise Finlay, Youssouf
Hassani, David J Baker
Violent Conflict and Asthma
Donata Garrasi
Economical Aspects of Climate Change
Erminia Ridolo (Section Leader), Marcello Montagni
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This document is a product of a joint initiative of the
2012–2013 WAO Committee on Climate Change and Biodiversity and the 2012–2013 WAO Committee on Asthma.

Air pollution episodes
Introduction

Air pollution is an alteration of the levels of quality and
purity of the air due to natural or anthropogenic emissions of chemical and biological substances. In the last
century, the massive increase in emissions of air pollutants due to economic and industrial growth has made
air quality a major problem for many countries in industrialized and industrializing countries and an emerging
problem for the rest of the world. At the present time, it
is mainly the vehicular pollution that degrades the quality of air in the cities of industrialized countries, whereas
industrial pollution still constitutes the largest source of
air pollution in countries undergoing industrialization.
However, other sources of pollution should not be underestimated. Desert sand, sea salt, wildfires, and volcanic ash
are considered as natural pollution and have to be added
to levels of particulates that pollute the air. The return to
wood for heating observed in the last decade is another
source of pollution. Although wood energy has an indisputable advantage in regard to greenhouse gas emissions,
it is a source of other gaseous and particulate pollutants.
Other forms of air pollution are pollens and mold spores.
In addition, people are exposed to air pollution also within
premises such as houses, offices, and schools, where they
spend between 80 % and 90 % of their time.
Today, tens of thousands of known or suspected air
pollutants, sometimes acting in synergy with each other
as well as with other parameters (temperature, wind,
etc.), are taken into account. However, only those factors
mandated by legislation are monitored. Indoor environments are a mixture of chemical pollutants and allergens
such as paints, adhesives, flooring chemicals, cleaning
products, combustion products from heaters and cooking, asbestos, animal allergens, mycotoxins, and fungal
allergens. Moreover, with its 3000 compounds identified
to date and its 5 billion particles per cigarette, tobacco
smoke is unquestionably the most formidable of air pollutants related to human activity.
We discuss in this section the links between air pollution episodes and asthma by stressing the underlying
mechanisms.
Mechanisms
Air pollution and inflammation

In vitro studies suggest that air pollutants modulate various inflammatory parameters at the cellular level. Ozone
has strong oxidation activity and can induce the release
of inflammatory mediators such as hyaluronan [4], platelet activating factor (PAF) [5], interleukin (IL)-1β, −6, −8
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and tumor necrosis factor (TNF)-α [6] from lung cells.
Similarly, environmental particles have been shown to
induce release of TNF-α and macrophage inflammatory
protein (MIP)-2 from murine lung cells [7]. On the
other hand, studies of human B cells demonstrated that
diesel exhaust particles (DEP) and polyaromatic hydrocarbons (PAH) derived from DEP can induce the synthesis of IgE in the presence of IL-4 and CD40 monoclonal
antibodies, suggesting that this pollutant may potentiate
sensitivity to common allergens [8].
Airway epithelial cells, which form the first line of innate defense against inhaled insults, play an important
role in the mechanism underlying pollutant-induced effects on airways. The studies of ozone, nitrogen dioxide
(NO2) and DEP have demonstrated that these pollutants
induce permeability of human bronchial epithelial cell
cultures while inhibiting ciliary beat frequency [9–13].
As a result, this may lead to a delayed clearance of allergens and irritants inhaled to airways. Furthermore, increased permeability of airways may result in increased
penetration of these agents to submucosa where they can
interact with residential cells such as airway smooth muscle
cells and fibroblasts as well as inflammatory cells including
mast cells, eosinophils, lymphocytes, and neutrophils.
Studies of airway epithelial cells also reported inflammatory effects of air pollutants [9, 10, 12, 14]. Ozone increased the release of inflammatory mediators including
PAF [5], IL-8, granulocyte macrophage-colony stimulating factor (GM-CSF), TNF-α and soluble intercellular
adhesion molecule (sICAM)-1 from human bronchial
epithelial cells (HBEC), which were suppressed by glutathione, an antioxidant that can be naturally produced in
cells [14]. Furthermore, NO2 enhanced release of leukotriene (LT) C4, GM-CSF, TNF-α, IL-8, regulated on activation normal T cell expressed and secreted (RANTES)
and sICAM-1 [9, 12, 15]. Similarly, DEP induced release
of IL-8, GM-CSF and sICAM-1 from primary human
bronchial epithelial cells [10]. Airway epithelial cells also
express HLA-DR and CD86 and can present antigen to
T cells. The expression of these co-stimulatory molecules is enhanced by DEP and mite antigen in mite
allergic patients [16].
Studies of asthmatic patients have suggested that their
airway epithelial cells are more susceptible to deleterious
effects of air pollutants. For example, although ozone and
NO2 did not affect the permeability of bronchial epithelial
cells obtained from non-asthmatic subjects, these gases increased permeability of those cultures of asthmatics [13].
Under standard culture conditions, asthmatic bronchial
epithelial cells produced greater amounts of IL-8, GM-CSF,
sICAM-1 and RANTES as compared to non-asthmatic
cells [11]. In addition, when these cultures were exposed to
ozone, NO2, and DEP, the release by asthmatic cells was
higher than cells of non-asthmatic subjects [11, 15].
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Air pollutants and oxidative stress

Reports indicate that the oxidative stress is increased
and the oxidant-antioxidant balance is tilted toward a
proinflammatory state in chronic airway diseases such as
asthma and chronic obstructive pulmonary disease (COPD)
[17, 18]. On the other hand, air pollutants lead to oxidative
and nitrosative stress in cell systems [19, 20]. Reports also
state that inhaled ozone has a powerful oxidant capacity
and that it can activate stress signaling pathways in epithelial cells and resident alveolar inflammatory cells. This
mechanism involves activation of the transcription factor
nuclear factor (NF)-κB and its translocation to nucleus
where it binds to DNA consensus sequences in the promoters of pro-inflammatory genes that code for inflammatory cytokines and chemokines, which attract neutrophils
and adhesion molecules [20]. Consequently, these molecules increase inflammatory cell recruitment into the airways and lung parenchyma and activate them for mediator
secretion and the capacity to cause tissue damage.
However, there may be differences between individuals
with respect to their response to inhaled ozone because
of genetic differences [19, 21]. The candidate genes, as
reported, included TNFα, manganese superoxide dismutase, glutathione peroxidase, NAD(P) quinone oxidoreductase, and glutathione S transferases (GST) [19]. Although
data are not consistent, polymorphisms of Glutathione
S-transferase Mu 1 (GSTM1), Glutathione S-transferase P
1 (GSTP1), and TNF-α reportedly have associations with
asthma and air pollution [22]. Together, these findings
emphasize the importance of locally available antioxidants
(uric acid, albumin, reduced glutathione, vitamin C, and
vitamin E) present in the lung lining fluid and epithelial
barrier, as well as the protective effect that diets supplemented with antioxidants possibly provide [19]. Hence,
studies have demonstrated that glutathione, an antioxidant, can be produced intracellular and can prevent
ozone-induced inflammatory mediator release from human
bronchial epithelial cells [9]. In vitro studies suggest that
NO2, although less potent than ozone, can also activate
oxidant pathways [16, 19].
Inhaled particles in demonstrations also induce a strong
pro-inflammatory response in lung cells [10, 11, 23]. Particles activate oxidant pathways by inducing reactive oxygen
species both directly and through uptake into epithelial
cells and macrophages [24–26]. Recent studies reported
that DEP induced nitrosative stress in epithelial cells and
resident lung phagocytes through interactions of nitric
oxide and superoxide anion [20]. Consequently, this leads
to activation of transcription factors NF-κB and activator
protein (AP)-1 that can result in increased release of inflammatory mediators [19, 26, 27]. In the short term, there
is acute tissue damage with activation of the epidermalgrowth-factor receptor (EGFR) pathway and evidence for
organ-repair responses [28]. With the ongoing cycles of
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damage and repair, epithelial mucus metaplasia may occur,
while ongoing cytokine and chemokine secretion contributes to airway inflammation [19]. Furthermore, recent
studies reported that particles induced release of proinflammatory cytokines such as IL-1β and IL-8 from
HBEC by increasing intracellular Ca++ levels [29].
Cell cycle and death

Studies have suggested that air pollutants cause cell toxicity and modify the cell death and cell cycle of lung
cells. Ozone induced the death of fibroblasts obtained
from lung biopsies of normal subjects [4], while attenuating viability of both macrophage-like cells [5], and alveolar
macrophages harvested from bronchoalveolar lavage fluid
of normal individuals [30]. However, studies showed that
ozone also enhances proliferation of lung cells of rats by
inducing cell cycle [31]. Furthermore, studies of diesel exhaust particles (DEP) and fine particulate matter (PM2.5)
reported that lower doses of these pollutants induced proliferation of macrophages of mice, whereas higher concentrations enhanced cell death [32, 33]. Organic chemicals
extracted from DEP induced oxidative stress in normal
and transformed bronchial epithelial cells that led to increased expression of heme oxygenase 1, activation of
the c-Jun N-terminal kinase cascade, IL-8 production,
and induction of cytotoxicity [34]. Recent studies have
demonstrated that DEP, under serum free condition, induce cell proliferation and decrease apoptosis of alveolar
epithelial cells by mechanisms involving oxidative stress,
inhibition of p21CIP1/WAF1 expression and stimulation of
JNK and NF-κB pathways [27]. However, when fetal calf
serum is added, effects of DEP on cell death, cell cycle,
apoptosis regulating proteins, and IL-8 release were modulated through activation oxidant stress pathways, JNK
and NF-κB. These findings suggest that extravasation of
serum, as occurs in the inflamed airways of patients with
chronic airway diseases such as asthma and COPD, may
render airway epithelial cells more susceptible to the deleterious effects of air pollutants [35]. Studies of primary
bronchial epithelial cells cultured from subjects with
COPD supported these findings, and although DEP decreased the viability of COPD cells after 24 hours,
under observation these effects were present in cells
derived from non-COPD subjects after 72 hours [36].
Asthma and air pollution

Degradation of air quality caused by one or more variable
pollutants has been related to asthma. Outdoor air pollution exacerbates asthma in those who already have the
condition [38]. Outdoor levels of air pollutants have been
associated with asthma incidence but not clearly with
asthma prevalence at the population level. In addition,
a growing number of studies also show that children
living in environments near traffic have increased risks
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of asthma symptoms, asthma exacerbations, school absences, and asthma-related hospitalizations as well as
new-onset asthma [37, 38]. Recently, the Aphekom
project (www.aphekom.org), by considering individual
home addresses, calculated the number of cases of childhood asthma caused by living near a road with elevated
traffic-related pollution and acute asthma events related
to urban air pollution levels in 10 European cities [39]. Exposure to roads with high vehicular traffic, a proxy for
near road traffic-related pollution, accounted for 14 % of
all asthma cases in the study. Under the hypothesis of a
causal relationship between near road traffic-related pollution and asthma, 15 % of all episodes of asthma symptoms
were attributable to air pollution. However, without this assumption, only 2 % of asthma symptoms were attributable
to air pollution. Pollutants along busy roads are responsible
for a large and preventable share of chronic disease and related acute exacerbations in European urban areas.
Indoor levels of air pollutants other than environmental
tobacco smoking have also been related to asthma prevalence or symptoms by sparse studies [40–43]. Consistent
results support short-term (aggravation) and, although
more rarely, long-term (prevalence augmentation) effects
on asthma of poor air in indoor settings [40–42]. Environmental tobacco smoke is one of the most important risks
for respiratory symptoms and diseases worldwide. The evidence is also reliable for indoor nitrogen dioxide and particulate matter which have been associated with asthma.
Whereas formaldehyde and volatile organic compounds
seem to be the main pollutants in indoor settings, relevant
papers on respiratory disease are still scarce and limited to
asthma and bronchitis. Molds have been associated
with an increased risk of asthma and COPD. Contradictory results have been found between endotoxins
and asthma. The role of phthalates, persistent organic
pollutants, and flame retardants in respiratory diseases
remains to be established. However, episodes of air pollution in indoor settings have not been studied. Studies
focusing on indoor air pollutants should be developed
to better understand their involvement in the inception
and aggravation of respiratory diseases.
Mechanistic evidence from toxicological studies together
with recent information on genes that predispose towards
the development of asthma suggest that the link between
air pollution and asthma is biologically plausible.
Susceptible and vulnerable groups

If the entire human population is affected by the quality
of the air, there is a great variability in exposure to air
pollutants as well as in individual susceptibility, so that
the extent of the response to air pollution and related
health effects vary among individuals. Children are susceptible to the effects of air pollution because their lungs
and immune systems are developing, they are more
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active in environments with high levels of air pollutants,
and they receive higher doses of air pollutants compared
to adults because of differences in breathing rates and
patterns. Asthmatic children are even more susceptible
because of their inflamed and hyperreactive airways. The
elderly are another segment of the population potentially
at higher risk of health effects of air pollution because of
normal or pathological aging [40, 42]. However, few data
exist on elderly populations. Besides age, other factors
that contribute individual susceptibility are sex/gender,
underlying diseases, smoking and diet, physical activity,
body mass index (BMI), and genetic background.
In terms of increased vulnerability due to higher exposure, the Aphekom study showed that living near
the trafficked roads is the cause of 15 % of asthma in
children [39]. Recent data have indicated that socioeconomically disadvantaged populations are another
group at increased risk of air pollution effects because of
proximity of air pollution sources or reduced management [37]. The health system and the use of care may
also modulate the effects of air pollution.
Opportunities for intervention to reduce the burden of
asthma
Decreasing air pollution

Several intervention studies have indicated that decreasing
air pollution leads to a reduction of the burden of asthma.
Already in 1999 and 2002, McConnell et al., had suggested
that if air pollution levels were reduced to match levels in
the cleanest community, then annual asthma-related emergency department visit and hospitalization rates would be
predicted to decrease from 22 to 6 %, asthma-related school
absences could be reduced by two thirds [44], and new
cases of asthma among the most active children living in
polluted communities could decrease by 75 %.
Efforts to reduce downtown traffic congestion in Atlanta,
Georgia (United States of America) during the Summer
Olympic Games in 1996 resulted in decreased traffic density, especially during the critical morning period [45]. This
was associated with a prolonged reduction in ozone pollution and significantly lower rates of childhood asthma
events. Actually, peak weekday morning traffic counts
dropped 22.5 % (P < 0.001), and the number of asthma
acute care events decreased by 41.6 % (4.23 vs 2.47 daily
events) in the Georgia Medicaid claims file as well as
44.1 % (1.36 vs. 0.76 daily events) in a health maintenance
organization database, 11.1 % (4.77 vs. 4.24 daily events) in
2 pediatric emergency departments, and 19.1 % (2.04 vs
1.65 daily hospitalizations) in the Georgia Hospital
Discharge Database. Traffic counts were significantly
correlated with that day's peak ozone concentration
(average r = 0.36 for all 4 roads examined). In multivariate regression analysis, only the reduction in
asthma events recorded in the Medicaid database was
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significant (relative risk, 0.48; 95 % confidence interval, 0.44–0.86).
The alternative transportation strategy implemented
during the 2008 Summer Olympic Games in Beijing
(China) provided an opportunity to study the impact of
the control measures and weather conditions on air
quality and asthma morbidity. The average numbers of
outpatient visits for asthma were 12.5 per day at baseline
and 7.3 per day during the Olympic events [46]. Compared with baseline, the Olympic Games were associated
with a significant reduction in asthma visits (RR 0.54,
95 % CI: 0.39–0.75) [47]. Other examples of asthma
episodes following air pollution reduction have been
observed. Taken together, these data provide support
for efforts to reduce air pollution and improve health
via reductions in motor vehicle traffic.
Consideration of antioxidant supplementation in the diet

Other intervention approaches regarding dietary supplementation with antioxidants have been explored for the
possible reduction of asthma incidence or morbidity since
pulmonary and systemic oxidative stress increase inflammatory responses relevant to asthma and allergy. A few
small clinical trials suggest that specific antioxidants from
diet or vitamin supplements might improve asthma
control or lung function in asthmatic children or adults.
Although meta-analyses of observational epidemiologic
studies suggest associations between low dietary intake of
antioxidants and higher asthma/allergy prevalence, there
have been no longitudinal studies of dietary or vitamin
antioxidant use by mother or child and the development
of asthma or allergy. More studies focusing on supplementation of antioxidant sources are needed to evaluate
whether antioxidants reduce asthma incidence or improve
asthma control and to assess the possible benefits and
risks of trials in vulnerable populations with known deficiencies in dietary antioxidants who have limited access to
them and also are exposed to high levels of environmental
sources of oxidants [48].
Conclusions

Air pollutants exert their detrimental effects on airways
and lungs by: (1) attenuating ciliary activity of airway
epithelial cells, (2) increasing permeability of airway epithelium, (3) leading to inflammatory changes in cells of
airways and lung parenchyma, (4) and modulating cell
cycle and death of cells of respiratory system. Air pollutants show these effects by causing direct cellular injury or
by inducing intracellular signaling pathways and transcription factors that are known to be sensitive to the oxidative
stress. Reduction in exposures to air pollution in order to
prevent asthma episodes can be approached at a policy
level through changes in indoor and outdoor air pollution.
Beyond clinical and public health approaches to reduce
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exposure, another strategy to be used before clean air
goals are met is to decrease, when possible, the susceptibility of individuals to air pollution or to protect susceptible individuals.
Inadequate antioxidant defenses attributable to low levels
of antioxidants (for example, vitamin C and vitamin E) or
variations in the expression or function of enzymatic antioxidants (glutathione-S-transferases [GSTs]), offer promising chemoprevention targets to reduce the burden of
asthma [49]. Emerging research indicates that dietary
supplementation for individuals with low antioxidant
levels is one promising approach to reducing susceptibility to air pollution. A second approach involves induction of enzymatic antioxidant defenses, especially
for individuals with at-risk genetic variants of key antioxidant enzymes. Policies, prevention, advice and treatment need to protect all people and in particular the
most susceptible ones. More in general, the search for
mechanisms responsible for the effects of air pollution
needs to be pursued in future work, so that effective
prevention strategies can be implemented to protect
people, especially the most vulnerable.

Thunderstorm-related asthma
Introduction

There is evidence that, during pollen season, thunderstorms can be associated with allergic asthma outbreaks
in patients suffering from pollen allergy [50–66]. Pollen
grains can be carried by thunderstorms at ground level,
where, after rupture by osmotic shock, they may release
into the atmosphere part of their content, including
inhalable allergen-carrying cytoplasmic starch granules
(<5 μ) or other paucimicronic components. Such small
particles may be inhaled into the distal airways and induce asthma in subjects with pollen allergy [50, 51].
Demonstrations have shown that changes in the weather
such as rain or humidity may induce hydration of pollen
grains and sometimes also their fragmentation which
generates atmospheric biological aerosols carrying allergens [57, 60, 64].
During the first phase of a thunderstorm, patients suffering from pollen allergy may inhale a high concentration
of the allergenic material, like biological antigenic aerosols
dispersed in atmosphere, which can induce (severe) asthmatic reactions in some cases [51, 55, 61–70]. Thunderstorms can induce attacks of severe asthma [65–67] and,
in some circumstances, are a common cause of epidemics
of exacerbations of asthma requiring attendance at the
Emergency Department [64]. A study in New South
Wales, Australia found that thunderstorm outflows were
detected in 33 % of epidemics, compared with 3 % of nonepidemic days [64]. Furthermore, 48 % of epidemic days
during late spring and summer were associated with thunderstorm outflow (development of a system). Yet, the
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mechanisms involved in the release of allergens from pollens during thunderstorms and associated risk should be
known by physicians, not only allergists but also general
physicians (GPs) and pollen allergy patients, to help with
prevention. Information about the risk of an asthma attack
is relevant also in subjects affected only by seasonal allergic rhinitis. In addition, there is a potential risk of
thunderstorm-related relapse of asthma attacks in some
patients. The increase in frequency of thunderstorms in
some geographical areas due to climate change will potentially heighten the importance of thunderstorm-related
asthma exacerbations [65–69].
Allergenic pollen and pollen allergy

Though representing only a small proportion of the airborne particles present in the atmosphere, pollen grains
can be causative agents of allergic respiratory responses
in pollen allergic subjects, and pollen allergy due to its
elevated prevalence and associated costs is now a public
health problem [68–70]. In the European Union countries between 8 and 35 % of young adults show IgE
serum antibodies to the most commonly encountered
grass pollen allergens [71], and the cost of pollen allergy
in terms of impaired work fitness, sick leave, consulting
physicians, and drugs is very high.
During natural pollination, mature pollen grains are
dehydrated when they are released by anthers at the dispersal time. Once the pollen grains come into contact
with a wet surface, they absorb water undergoing rapid
metabolic change, and the pollen allergens are rapidly
released when the pollen grains come into contact with
the oral, nasal, or conjunctival mucosa, thereby inducing
the appearance of pollinosis symptoms in sensitized patients [72, 73]. The cytoplasmic allergens can be released
into the atmosphere when the pollen bursts under osmotic shock and can create an inhalable allergenic aerosol. In particular, it has been observed [72] that fresh
birch pollen can rupture in high humidity conditions
and release an aerosol characterized by fragments of
pollen cytoplasm ranging in microdroplets. Taylor et al.,
[73] observed that about 65 % of pollen grains grew a
pollen tube up to 300 μm long prior to rupture and release of their cytopasmic content in the high humidity
context. The released particles, such as fragmented
pollen cytoplasm, form an ultra-fine aerosol. The same
authors observed that grass anthers should be a site of
pollen rupture and a source of fine particulate aerosols
that contain pollen allergens [73].
The concentration of allergenic pollen influences the
degree of symptoms, but the relationship between allergen
exposure, inflammation of airways and clinical symptoms
is complex, and factors other than allergens are involved
[74]. Pollen grains penetrate into the upper respiratory
tract but, because of their size, which is always greater
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than 10 μm of diameter, the grains rarely reach the lower
respiratory tract. However, asthma due to pollen exposure
is not infrequent.
Rainfall is usually known to remove pollen from the
air but that is not always the case, because studies have
revealed that allergens leave the pollen surface almost
instantly, usually within seconds, upon contact with water.
The discovery of airborne allergen carrying particles much
smaller than pollen grains, such as those released by
pollens during weather perturbations, particularly thunderstorm and rainfall, provided a possible explanation
[50]. Indeed, the existence of allergen carrying airborne
particles much smaller than pollen grains (paucimicronic particles) can explain bronchial symptoms affecting
subjects during the pollen season or a thunderstorm
[50, 55–59]. Due to their size, these paucimicronic particles can penetrate deeply into the airways thus inducing asthma in sensitized atopic subjects. In addition,
in the context of paucimicronic particles there are orbicules, small granules (1–5 μm) or droplets developed
from anther tissues, loaded with allergens, and there is
evidence that these may play a role in allergic asthma
thus contributing to form a inhalable aerosol during
the pollen season [75–80].
Thunderstorms and allergic asthma epidemics in subjects
with pollen allergy during pollen season

There are descriptions of thunderstorm-related asthma
outbreaks in various cities such as Birmingham (United
Kingdom) [52], London (United Kingdom) [56, 59],
Melbourne (Australia) [53], Wagga Wagga (Australia)
[63], and Naples (Italy) [65], but there are case reports
in other cities [66, 67].
One of the first observations regarding thunderstorms
and asthma outbreaks was provided by Packe and Ayres
[52] at the East Birmingham Hospital, Birmingham on 6
and 7 July 1983. These authors describe a striking increase
in the number of asthma Emergency Department visit admissions during the period of a thunderstorm. During a
period of 36 h, 26 asthma cases were treated in the Emergency Department, compared with a daily average of two
or three cases in the days preceding the outbreak.
Another asthma outbreak occurred in London which
coincided with a heavy thunderstorm on 24 June 1994,
when a large increase was observed in the number of visits
for asthma at the Emergency Departments of London and
the southwest of England (United Kingdom). Several of
the reported patients had a prior history of seasonal rhinitis but not asthma [56, 59]. The epidemic had a sudden
onset on 24 June 1994; 640 patients with asthma or other
airways diseases visited Emergency Departments during
30 h from 18.00, nearly 10 times the expected number.
Over half (365) the patients were aged 21 to 40 years. A
history of hay fever was recorded in 403 patients; for 283
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patients this was the first known attack of asthma. A history of chronic obstructive airways disease was recorded
in 12 patients. In all, 104 patients were admitted (including 5 to an intensive care unit). Six hundred and four
(604) patients with wheezing and shortness of breath were
seen in several departments, compared with an expected
number of 66.6 [56]. These results confirm an asthma epidemic, with almost 10 times the usual number of patients
presenting during 30 h and an excess of 574 patients attributable to the epidemic [56, 59]. The outbreak was not
restricted to the London area, although the number of patients presenting to Emergency Departments on the night
of 24 June 1994 was greater in the Thames regions than in
other regions in England. Moreover, not all affected patients attended hospital, and this epidemic was the largest
outbreak ever recorded.
Other asthma outbreaks during thunderstorms were
described in Melbourne (Australia) [53], where two large
asthma outbreaks coincided with thunderstorms. These
events also were followed by a rapid increase in hospital
or general practitioner visits for asthma. Taking into account the Melbourne experience, a similar mechanism
could have been involved, although other factors may have
also contributed. Further asthma outbreaks occurred in
Wagga Wagga (Australia) on 30 October 1997 [63] and in
Naples (Italy) on 4 June 2004 [65]. In Wagga-Wagga 215
asthmatic subjects attended the local emergency department, 41 of whom required admission to hospital. Marks
et al. [64] demonstrated that the arrival of a thunderstorm
outflow was accompanied by a large increase in the concentration of ruptured pollen grains in ambient air. It
seems likely that the outflow of air from the upper thunderstorm cell, rather than electrical activity, thunder or
rain alone, is responsible for the observed event (Fig. 1).
Furthermore, 96 % of affected individuals had positive skin
prick tests to rye grass pollen, compared with 64 % of
other patients with asthma (adjusted odds ratio 23.0, 95 %
confidence interval 6.6 to 84.3), and 90 % of thunderstorm
cases reported recent hay fever symptoms compared with
69 % of other patients with asthma [63]. During the
episode of thunderstorm-associated asthma registered
in Naples on 4 June 2004 (between 1.30 and 2.00 am), 6
adults (3 women and 3 men between 28 and 60 years
old) and a girl of 11 years had attacks of severe asthma,
which in one case was nearly fatal. All patients received
treatment in Emergency Departments and one was admitted to an intensive care unit for very severe bronchial obstruction and acute respiratory insufficiency.
All individuals were outdoors when the thunderstorm
struck. All seven patients were sensitized with allergic respiratory symptoms upon exposure to Parietaria pollen
but were not sensitized to grasses [65]. Parietaria is an
Urticacea that is widespread in the Naples area with a
spring and summer pollen season, in part contemporaneous
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Fig. 1 Chart showing the relation between airborne pollen
concentrations and the arrival of the thunderstorm outflow in
Wagga Wagga (Australia). Closed circles represent intact pollen
grains. Open circles represent empty pollen husks. The data are
plotted at the midpoint of the hour over which the concentrations
have been measured. Data for wind speed, wind direction, and
rainfall were recorded each minute by analogue chart recorder and
have been scanned into the figure. The vertical dashed line
represents the time at which the first ambulance call, seeking
assistance for an attack of asthma, was received in Wagga Wagga.
Examination of the recorded radar images (not shown) reveals that
the line of the thunderstorms arrived at the site of the Burkard trap
about 10 min before it reached the AWS. Reproduced with
permission from BMJ Publishing Group Ltd [64]

with that of grasses [68–70, 80]. During the thunderstorm,
the concentration of airborne Parietaria pollen grains was
particularly high with a peak of 144 grains/m3 being recorded on 3 June 2004 [65, 81].
Possible mechanisms for thunderstorm asthma

Although much remains to be understood about the relationship between an increase in the number of asthma
attacks and thunderstorms, reasonable evidence exists in
favor of a causal link in patients suffering from pollen allergy [50–67, 76, 77] (Table 2). What is most frequently
hypothesized is that dry updrafts entrain whole pollens
into the high humidity at the cloud base of a thunderstorm where pollens may rupture and cold downdrafts
carry pollen fragments to ground level. In other words,
at the onset of a thunderstorm, pollen fragments are
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Table 2 Characteristics of described epidemics of
thunderstorm-associated asthma
There is a link between asthma epidemics and thunderstorms.
The epidemics related to thunderstorms are limited to seasons when
there are high atmospheric concentrations of airborne allergenic
pollens.
There is a close temporal association between the start of the
thunderstorms and the onset of epidemics.
There are not high levels of gaseous and particulate components of air
pollution during thunderstorm-related asthma outbreaks.
Subjects with pollen allergy who stay indoors with windows closed
during thunderstorm are not affected.
There is a major risk for subjects who are not optimally treated for
asthma; but subjects with pollen-induced allergic rhinitis and without
prior asthma are also at risk.

carried to ground level where outflows distribute them.
As a consequence, there is a high inhalable allergen load
in the air. Taylor et al., [73] hypothesized that the turbulent front of the advancing outflow releases more pollen
from flowering grasses, and then may entrain them into
the cloud base. Strong electric fields develop in the thunderstorm. Positive ions are released from the ground and
attach to particles and electric charge may enhance pollen
rupture. Grass pollens, after rupture by osmotic shock
during thunderstorms, release large amounts of paucimicronic allergenic particles. Because of their very small size,
these microparticles can penetrate the lower airways inducing the occurrence of bronchial allergic symptoms.
Pollen grains are ruptured in rainwater by osmotic shock,
with each grain releasing around 700 starch granules that
are small enough to penetrate the airways and trigger
asthma attacks in previously sensitized subjects. These phenomena were observed while levels of chemical air pollution were below or similar to levels in a control period.
Depending on the size of the population at risk,
thunderstorm-associated asthma outbreaks may threaten
the operative capacity of health services, as was the case
in London and in Wagga Wagga. However, relapse of
thunderstorm-related asthma attacks is possible, and there
are descriptions of three different events in the same subjects in different years, as in the case of a pregnant woman
which will be discussed later [81, 82]. An association between emergency visits for asthma and thunderstorms has
been related to an increase in airborne fungal spore
counts in Canada and the United Kingdom [83, 84]. A
predictive model for hourly concentrations of atmospheric
Alternaria and Cladosporium spores on days with summer storms in Poland was created through meteorological
conditions and predicted spore concentration in advance
on such days. Both allergic and non-allergic mechanisms
have been implicated in the association between exposure
to high concentrations of ruptured Alternaria spores and
the exacerbations of asthma [86, 87]. Thunderstorm
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asthma does not accompany all thunderstorms. Despite published evidence being limited and highly variable in quality due to thunderstorm asthma being a
rare event, there is evidence for the role of aeroallergens, meteorological features, and the impact of thunderstorm asthma on health services [87].
Is there a risk of relapse of thunderstorm-related asthma?

Whereas there is increasing evidence of a possible link
between thunderstorms and asthma, the fact that relapses of thunderstorm-related asthma are also possible
is less well known. To date, the first and only reported
case of relapse of near fatal thunderstorm-related asthma
occurred in a 36-year old woman who was 20 weeks
pregnant, affected by seasonal asthma, and sensitized to
Parietaria pollen [82]. She had experienced near fatal
asthma with a thunderstorm in June 2004 and had been
treated in the emergency department of Cardarelli
Hospital in Naples. She was admitted to the Emergency
Department of the same hospital 7 years later, on 24
May 2011, despite appropriate treatment with oxygen
and 2 g i.v. methylprednisolone on admission. Clinical
parameters were similar to those during the first episode.
Since the first episode the patient had avoided being outdoors during an approaching thunderstorm. The second
time, an unexpected thunderstorm occurred while she was
driving her motorbike, and she experienced increasing dyspnea that had to be treated in the Emergency Department
some hours later. On those days, the Parietaria pollen
count was higher than in the past 10 years in Naples
during the same time of the year (260, 113, and 79.4
pollen x m−3 air in the previous 3 days, respectively), but
no air pollutants were observed. Her symptoms became
stable within a couple of weeks following a short course of
treatment with oral corticosteroids [82].
Protection against thunderstorm-induced asthma

Since a thunderstorm-induced asthma attack represents
a high dose allergen challenge, and there is evidence that
inhaled corticosteroids are protective against airway
hyperresponsiveness, it is reasonable to hypothesize that
regular treatment with inhaled corticosteroids might reduce the risk of severe thunderstorm-induced exacerbations of asthma in pollen-allergic individuals. There is
no direct evidence to support this, but two studies have
shown that affected patients in thunderstorm-related
epidemics were unlikely to be taking inhaled corticosteroids [63, 88].
Necessary conditions for a thunderstorm-related epidemic
to occur

It has been proposed that the following four conditions
are necessary for a thunderstorm-related epidemic to
occur [85].
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1. An abundance of grass pollen or fungi (in particular
Alternaria)
2. A thunderstorm outflow concentrating the allergenic
material at ground level near a population center
3. The formation of inhalable (<10 μm) particles either
by rupture of pollen grains or germination of fungal
spores
4. Exposure of sensitized individuals with untreated or
uncontrolled airway hyperesponsiveness to an air
mass containing the highly concentrated allergenic
particles.

Conclusions

Thunderstorm-associated asthma is a dramatic example
of the allergenic potential of pollen and fungal antigens.
Pollen-allergic patients who encounter the allergenic
cloud would be more susceptible to undergo an asthma
attack. Subjects allergic to pollen who are in the path of
the thunderstorm outflow are likely to inhale airborne
pollen allergens and to experience an airway asthmatic
response. Relapse is also possible.
Subjects affected by pollen allergy should be informed
about a possible risk of asthma attack and possible relapse
at the beginning of a thunderstorm during pollen season.
Subjects with a high degree of pollen allergy should
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consider staying indoors with closed windows if a strong
thunderstorm is approaching.

Sandstorms
Introduction

A dust storm or sandstorm is a meteorological phenomenon
common in arid and semi-arid regions. Dust storms
arise when a gust front or other strong wind blows
loose sand and dirt from a dry surface. Once airborne,
smaller sand particles (<100 μm) can remain airborne
for days and be transported hundreds of miles. There
are nine regions that contribute to the total global production of desert dust: North Africa (Sahara), South Africa,
the Arabian Peninsula, Central Asia, Western China,
Eastern China, North America, South America, and
Australia [89] (Fig. 2). Regions of the world in the path
of dust-laden wind record increased ambient air dust
concentrations that are temporally associated with deteriorations in air quality. Although estimates of the
contribution of the different source areas are difficult
to make, it is agreed that North Africa is the main
source area with over 50 % of the total desert dust
found in the atmosphere (the Sahara region accounts
for 58 %), and almost five times as much as the second
biggest source (the Arabian Peninsula) [89].

Fig. 2 Meteorological observations and modeling have identified ten main sources of global dust events, shown in Fig. 2: (1) the Salton Sea, (2)
Patagonia, (3) the Altipläno, (4) the Sahel region, (5) the Sahara Desert, (6) the Namibian desert lands, (7) the Indus Valley, (8) the Taklimakan
Desert, (9) the Gobi Desert, and (10) the Lake Eyre basin. Adapted with permission from Environmental Health Perspectives [136]
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Health hazards of sandstorms

Smith et al. (1999) estimated that 25–33 % of the global
burden of diseases can be attributed to environmental
risk factors [90] including acute respiratory infections.
There is enough data on the health-related impact of the
anthropogenically generated particulate matter (PM), such
as PM generated by combustion engines [91]. However,
not as much work has looked at the impact of naturally
generated PM (such as PM emanating from dust storms).
Many studies have investigated the health risks of dust
storms, and changes in morbidity, hospital admissions,
or mortality before, during, and after dust events. Others
compared health effects on at-risk populations compared
to control groups between days with dust events and
control days. A number of adverse health effects, including respiratory diseases (asthma and pneumonia),
cardiovascular diseases (ischemic heart disease, cerebrovascular disease), chronic obstructive pulmonary
disease (COPD), conjunctivitis, and allergic rhinitis,
were shown to be associated with dust [92]. Several
studies from various geographical settings also looked
into the short-term health effects of dust storms with
a significant association between dust storms and allcause hospital admissions [93].
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Sandstorm dust particles and allergen contents and their
impact on the respiratory system
Sand microparticles

Many factors are associated with the increased effect of
dust storms on the respiratory system. PM size is one of
them. Samples taken in the Saudi Arabian peninsula
ranged in size from less than 2 to 20 μm with more than
85 % of particles measuring less than 10 μm in diameter.
Particles smaller than 2.5 μm can penetrate into the gasexchange region of the lung. Draxler et al., (2001) reported
similar findings from air samples collected at 9 sites across
Kuwait and Saudi Arabia [101]. Although typically small
and insoluble, these dust particles carry various soluble
contaminants on their surface or within their matrix.
The histologic detection of Middle East sand particles
(MESP) in rodent lungs, 6 months following a single exposure, suggests that multiple exposures may lead to a
substantial lung burden and high levels of biological and
metal contaminants [102]. During a single dust storm,
which has an average duration of 10 h, an unprotected
individual might inhale as much as 5.4 mg of dust [103].
Although coarse particles have been described to be less
toxic than fine particles, they had stronger effect in inducing inflammatory mediators, which are essential in
asthma attacks or other respiratory disorders [104].

Prevalence of asthma in regions with high sandstorm events

Asthma is a serious and prevalent public health problem
that spans the entire world, with over 300 million people
affected worldwide. Although Asia is only the third
source area in terms of dust quantities emitted, after
North Africa and the Arabian Peninsula, it is the world’s
most studied region in the literature linking desert storm
and air quality [94]. Several studies conducted in areas
with a high rate of sandstorms, like most of the Arabian
Peninsula countries, confirmed the increased prevalence
of asthma in those countries. Asthma Insights and Reality
in the GNE (AIRGNE) survey conducted in five Gulf Cooperation Council (GCC) countries involving 1000 patients
with asthma revealed several striking findings. Use of health
services in the last 12 months was high, with 23 % having
been hospitalized and 52 % having attended the Emergency
Department. Absence from school and work in the year
was reported by 52 % of children and 30 % of adults [95].
Several other studies reported a high prevalence of asthma
in these countries including Saudi Arabia (25 %) [96], UAE
(15.4 %) [97], Qatar (19.8 %) [98], and Kuwait (15.6 %) [99].
The studies showed that asthma is largely uncontrolled in
the Middle East, with persistent adverse effects on the
psychosocial and productive life of the patient. In addition,
a recent study examining more than 40,000 military
personnel of the United States of America described an
association between service in Iraq and the development of respiratory diseases including asthma [100].

Gaseous and mineral contaminants

Air quality is usually based on various indicators such as
the mineral concentrations of SO2, NO2, O3, and CO,
in total suspended particulate (TSP), and PM [103]. Depending on their origins, these particles vary in their
composition (Table 3). Sahara dust, for example, is mainly
made up of clay minerals, quartz, calcium, and magnesium carbonate, while particles of anthropogenic origin
seem to be mainly composed of carbon-containing particles, sulphates, and nitrates. However, dust storm from
the Gold Coast in Australia showed a large fraction of fine
particles with an increased amount of total suspended
solids, aluminum, iron, and manganese, which are common soil minerals in Australia [106] (Table 3).
Sand in the Middle East is primarily a mixture of silicate
minerals, carbonates, oxides, sulfates, and salts in varying
proportions [103]. Soil samples analyzed by Englebrecht
et al., (2009) exhibited high percentages of quartz in all
areas within the Middle East, except for those collected in
Iraq [103]. Quartz, an amorphous and crystalline silica, is
known to cause respiratory disease in occupationally exposed people and highly exposed people who live close to
deserts [107]. Therefore, it may be postulated that the
high concentrations of this mineral in suspended dust
may give rise to allergic reactions within atopic asthmatics.
Aluminum, iron and magnesium were also found to be
particularly prevalent in dust samples gathered in Kuwait.
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Table 3 Origin of desert dust storms and composition of minerals (in the nine potential dust source regions in the world)
Dust source
regions

Origin of dust storm

Composition of minerals

Australian
dust

New South Wales and north-east South Australia

Aluminum, iron, manganese [106].

North Africa Bodélé Depression and area covering eastern Mauritania,
(Sahara) dust western Mali and southern Algeria.

Clay minerals, quartz, calcium, magnesium, carbonate [105].

Asian dust
Taklamakan Desert in XinJiang Province of China and the
(Central Asia) Gobi Desert located in Inner Mongolia

Aluminosilicate, cadmium, calcium, manganese, nickel, arsenic,
silicon dioxide, calcium carbonate, and organic compounds coated
by nitrate [131].

Arabian
Peninsula

Sudan, Iraq, Saudi Arabia and the Arabian Gulf

Mixture of silicate minerals, clays, quartz, carbonates, oxides, sulfates, and
salts in varying proportions [103].

Western
China

The western desert in China

Aluminum, iron, magnesium, and scandium [132]

Eastern
China

Source regions to the northeast of the Tibetan Plateau

Magnesium, aluminum, silicon, potassium, calcium and iron; Illite is the
principal clay mineral, and quartz [132].

North
America

Central US, deserts of Arizona, cities of Yuma and
Phoenix, New Mexico, Texas, and Canada during the Dust
Bowl

Sulfur dioxide, nitrogen dioxide, cobalt, PM10 > 1000 μg m␣3 [133].

South
America

Argentine loess, Southern Ocean sediments and Antarctic
dust, and Puna-Altiplano plateau

Sandy silts [134].

South Africa

Namibian desert lands, Kalahari, and Karoo

Fine grained alluvial and lacustrine sediments [135].

Magnesium and aluminum are irritants of the mucus
membranes in the proximal airways [108].

metal, and other regional contaminants adhering to the
particle surface, are not fully understood and require
further investigations [112].

Microbial and other allergens components

More than 200 culturable prokaryotes were detected in
desert soils across the Middle East including diphtheroids, beta hemolytic bacilli, and Bacillus species. Lyles
et al., identified over 147 bacterial isolates and 27 fungal
isolates from Kuwaiti and Iraqi dust [109].
Sandstorm dust collected in Riyadh was found to contain 869 cfu (colony forming units) of fungi and 1892 cfu
of bacteria per gram of dust. Comparison of these results
to the colony counts in regular airborne dust indicated
that, during sandstorms, fungal counts increase by 40 %,
while bacterial counts increase by 100 %. The most frequently isolated bacteria were species of Actinomyces,
Bacillus, Pseudomonas, and some coagulase-negative
Staphylococci. Most common fungal isolates included
species belonging to Aspergillus, Cladosporium, Mucor,
Penicillum, Ulocladium, and Alternaria [110].
Furthermore, viruses and fungal spores are common
components of Middle East dust. There are more recent
demonstrations that influenza A virus can stay in ambient
air during dust storms and can be long-range transported
[110]. Moreover, in vitro cell culture studies suggested that
sand dust enhances virus-induced cytokine secretion and
viral replication in human nasal epithelial cells [111].
Date-palm pollen was also singled out as an important
aeroallergen within sandstorm dust. Once inhaled, the
in vivo effects of these dust particles and the biological,

Clinical impact of sandstorm dust exposure on asthma

Dust storm events were associated with asthma and respiratory admissions to hospitals in many studies. However, the effect varies among published studies. Although
many studies have shown a significant increase in asthma
exacerbations and hospital admissions, others have shown
only mild association with no statistical significance between asthma outcomes and dust storm exposure.
On the other hand, other studies showed that the influences of dust storms on lower respiratory tract symptoms,
upper respiratory tract symptoms, ocular symptoms, and
skin symptoms were often different for each dust day in
patients with asthma, with only 4 % of the patients consistently showing exacerbations of lower respiratory tract
symptoms on every sand storm day, and 48 % of the patients were completely unaffected by the event [113].
Factors like the levels of anthropogenic metals (such as
cadmium, manganese, and nickel) and sulfur dioxide
(SO2) can induce airway inflammation and/or bronchoconstriction [114], and these may enhance the dust storm
impact on the lungs. Dust microbial contaminants can
cause severe asthmatic attacks and are capable of provoking respiratory arrest in children and young adult
asthmatics [115]. This is of utmost importance due to
the high rates of childhood asthma in the Middle East.
Similarly, pollens have been attributed to worsen asthma
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exacerbations during seasonal dust storms [116].
Watanabe et al., showed worsening asthma symptoms
during dust dispersion period, defined as the dust
storm day plus the next 6 days in April in Japan, when
Japanese cedar pollen levels were increased, which was
more common in patients with allergic rhinitis or
atopy than in those without [116].
On the other hand, Kwaasi et al., (1998) analyzed IgE
reactivity in relation to gathered sandstorm dustfall in
Riyadh among three groups: normal subjects, atopic patients, and gardeners. Reactivity was particularly high
among the pre-exposed gardeners (73 %) and the atopic
group (68.8 %). Furthermore, skin-prick test (SPT) on
the 45 atopic patients with ordinary Riyadh dust extract
gave positive results in 25 % of atopic individuals, while
SPT with sandstorm dust extract provoked a positive response in 47 % of these patients. This further supports
the justification of pre-emptive steroid inhaler use prior
to predicted sandstorms or on initial identification of the
presence of a sandstorm [117].
Clinical impact of sandstorm dust exposure on asthma in
children

Among the different age groups, children are particularly
sensitive to airborne exposure; however, few studies have
focused on children’s health from the perspective of dust
storm events [118]. Parents of schoolchildren aged between
6–14 years in Al-Ain (Abu Dhabi) were interviewed regarding the nature of their child’s asthma. They identified dust
storms as one of the major precipitating factors for asthma
attacks among their children. Kantani et al., reported a
greater increase in hospitalizations of children than adults
in Japan during dust storms, and, reflective of the Al-Ain
results, recorded more admission for boys aged 6–12 years
in the acute period. However, girls and infants of both sexes
were more frequently admitted several days after the dust
event [119]. Thalib and Al-Taiar (2012) examined the correlation between dust storms and hospital admissions due
to asthma across government hospitals in Kuwait over five
years [94]. They found that the only statistically significant
group was that of the children 0–14 years old compared to
adults. Yu et al., analyzed the effect of 76 dust storm events
(Asian dust storm) during the period of 1997–2007 on
respiratory clinic visits of preschool and school children.
Children’s respiratory clinic visits happened 5 of the 7 days
after a sandstorm event [118]. Apparently the pediatric
population is the most vulnerable age group to sandstorm
dust events exposure.
Effect of sandstorm dust exposure on lung function and
pathology

Numerous environmental factors have been implicated
in the development of asthma, including air pollutants,
tobacco smoke, aeroallergens and dust particles. During
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sandstorms, epithelial exposure to dust microparticles
and its allergen components may result in epithelial
deformity, detachment, or destruction of this vital airway
barrier [120]. This may trigger signals to the underlying
mesenchyme to propagate and amplify inflammatory and
remodeling responses in the submucosa. In addition to the
airway epithelium, airway smooth muscle responds to environmental factors, including dust and allergens via mechanisms that are independent of the immune system [121].
Murine studies have also confirmed the pathogenicity
of dust particles on lung pathology. Wilfong et al.,
(2011) administered intratracheal dust samples collected
from across Kuwait to experimental rats. Subsequent effects on the respiratory system were analyzed. Levels of
total protein, neutrophils, and several cytokines and chemokines were noted to be elevated following exposure
to dust particles. This data suggested a transient inflammatory response lasting several days, further strengthening the agreement for use of inhaled corticosteroids in
the acute phase as well as over the following days [98].
Ichinose et al., (2008) found that upon removal of Asian
Sand Dust (ASD) contaminants, such as sulfates (SO4)
and nitrates (NO3), and microbiological materials including lipopolysaccharide and β-glucan, the resulting
inflammation in murine lungs was significantly reduced,
including allergen-related eosinophil recruitment [122].
Impact of sandstorm on the development of other
diseases

In addition to association with asthma, several studies
indicated a clear association between dust storms and
cardiovascular, respiratory dysfunction, and allergic rhinitis [123]. One of the earliest studies by Korényi-Both
et al., reported an acute desert-related disease, which
was manifested with hyperergic lung condition due to
inhalation of fine Saudi sand dust contaminated with
pigeon droppings. It was described as desert storm pneumonitis, and named as Al Eskan disease [124]. Inhabitants of deserts may develop Desert Lung Syndrome, a
benign, nonprogressive fibrosis resulting from silicacontaining dust depositing in the lungs following heavy
exposure [125]. A correlation between metal-containing
particulates and increased lower-respiratory-tract infections and chronic fibrotic lung disease has also been well
documented in occupational environments [126]. Moreover, upon examining lung biopsies of 49 military personnel
returning from Iraq, a more recent study suggested their
development of constrictive bronchiolitis due to exposure
to Iraqi dusty environments [127].
Preventive measures and treatment approaches to
asthma upon exposure to sandstorm dust

Prevention and mitigation strategies are critically important to reduce the deleterious effects of sandstorm dust on
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public health and vulnerable groups including asthmatic
patients. Such strategies should include reducing the production of greenhouse gases (GHG), since the emission of
these gases is known as the primary cause of global climate change [128], and targeting decreases in precipitation and increases in temperature and land degradation
and desertification. In fact it has been demonstrated that
vegetation cover can increase the surface roughness and
slow or halt a dust storm [129].
A protective measure against sand dust inhalation, to
some extent, could also be the use of dust masks and
respirators. It seems that these masks can be used for
personal protection from sand dust particles, whose size
varies between 2 and 20 μM as demonstrated in samples
collected from various sites in Saudi Arabia and Kuwait
[101]. Air filtration systems may also be efficient in reducing air dust levels [130]. However, there is an urgent need
to conduct detailed research to establish the value of such
devices for public protection during sandstorm events.
Local authorities and health institutes should set up
monitoring and alert systems, which could forecast sandstorms and inform communities about pending extreme
weather events and dust storms. Hospitals, first step
health care, day care, and emergency health care facilities
should be re-organized and maintained. Physicians and
healthcare personnel, as well as communities, should be
educated on preventive measures and developing corrective behavior against sandstorm events. For example, asthmatic patients should be trained for specific measures to
take before and during sandstorm days. Children in the
Arabian Peninsula and surrounding countries are susceptible to the airborne irritants in dust storms, possibly
more-so than are adults. It is hence suggested that asthmatic children’s action plans are optimized, that they
always carry their reliever inhaler, and that they are familiar with its use in an appropriate manner and at an appropriate time. Physicians and public health officials should
educate parents and children concerning the management
of asthma during dust storms: minimizing outdoor activities, proper use of air filtration masks, and the thorough
cleaning of residential areas and schools following dust
storms. The community owes children the provision of a
school environment that is clean and dust-free, and has
proper air-flow mechanisms and insulation. However, the
most important preventive measure by health professionals and physicians is with no doubt the modification
of patients’ medications. In particular, the dose of antiasthmatic drugs including inhaled steroids should be optimized before, during, and after sandstorm days.
Conclusions

There is a growing body of evidence showing that air
quality deterioration caused by desert dust storms is associated with significant impacts on human health, in
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particular on asthma exacerbations and respiratory hospital admissions. This effect was more pronounced on
vulnerable pediatric populations with asthma. Evidence
suggests that several factors related to the nature of the
particulate of which these dust and sandstorms is comprised may be detrimental to the respiratory health of
asthmatics. In light of the high prevalence of asthma, it is
imperative that continued research is carried out into the
nature of sand and dust storms, such that suitable treatment options can be defined and preventative measures
may be implemented. To our knowledge, empirical evidence assessing the efficacy of medical interventions in
the treatment and/or management of the effects of dust
and sandstorms on asthmatics is lacking. More research is
needed on this topic, particularly on the success and feasibility of medical treatment and prevention strategies.

Climate change and respiratory allergy
Introduction

As mentioned earlier, it is now widely accepted that the
temperature of Earth is increasing, as confirmed by warming of the oceans, rising sea levels, glaciers melting, sea ice
retreating in the Arctic, and diminished snow cover in the
Northern Hemisphere. Moreover, changes are also occurring in the amount, intensity, frequency, and type of precipitation and in occurrence of extreme events such as
heat waves, droughts, floods, and hurricanes. As stated in
the recent Working Group I Report of the Intergovernmental Panel on Climate Change, “most of the observed
increase in globally averaged temperatures since the mid20th century is very likely due to the observed increase in
anthropogenic greenhouse gas concentrations …” [137].
Carbon dioxide (CO2) is the most important anthropogenic greenhouse gas, and its atmospheric concentration
has increased from a pre-industrial value of about 280 ppm
to 379 ppm in 2005. About 75 % of the anthropogenic CO2
emissions to the atmosphere during the past 20 years resulted from fossil fuel burning; most of the rest resulted
from changes in land use, especially deforestation. The
same trend occurred for the other prevalent anthropogenic
greenhouse gases: methane (CH4), and nitrous oxide (N2O)
[137]. Major changes involving the atmosphere and the
climate have a major impact on the biosphere and human
environment. Many prevalent human diseases are linked
to climate fluctuations, from cardiovascular mortality and
respiratory illnesses due to heatwaves, to altered transmission of infectious diseases and malnutrition from
crop failures [137, 138].
A number of reports on time trends in allergic respiratory diseases including asthma have shown a substantial
increase in prevalence since the early 1960s. However,
accumulating evidence indicates that rising trends in
prevalence of asthma and atopy among adults and older
children may have plateaued or even decreased after
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increasing for decades, especially in countries with existing high prevalence. Data from younger childhood are
less reassuring [139–151].
The effects of climate changes on respiratory allergy
are still unclear and current knowledge is provided by
epidemiological and experimental studies on the relationship between asthma and environmental factors, like meteorological variables, airborne allergens and air pollution.
Data about the influence of weather on asthma, are poor
and inconclusive. Weather affects asthma directly, acting
on airways, or indirectly, influencing airborne allergens
and pollutants levels. The complexity of the aerosol reaching the airways and the several compounds that play a role
in this relationship might explain the controversial results
of studies conducted so far.
Indoor and outdoor allergen exposure is a well-known
aggravating factor for asthmatic patients even if its role
in asthma development is not fully understood. Pollen
grains are responsible for seasonal exacerbations of allergic asthma and rhinitis, and they disperse according to
the flowering period of the plant of origin. Of great importance is the knowledge of plant geographical distribution and their flowering period and possible variations
induced by climate change scenarios [77, 152–158].
Numerous studies have shown that air pollution is
consistently associated with adverse health effects, and it
has a quantifiable impact on respiratory diseases, cardiovascular diseases, and stroke. Data linking changes in
environmental variables and changes in incidence and
prevalence of asthma are still lacking, even if an increasing
body of evidence shows the adverse effects of ambient air
pollution on allergic respiratory diseases [139, 155–158].
The aim of this section is to briefly discuss current
concepts in the field of environmental factors affecting
allergic respiratory diseases and hypothesize possible
long-term effects of climate change (see Table 4). Possible impacts of climate change on allergy and asthma
prevalence are beyond the purposes of this work, even if
the role of predictable changes in air pollution and aeroallergen exposure will be considered.
Weather

Data about the influence of weather on asthma are inconclusive and debated. Weather affects asthma directly, acting
on airways, or indirectly, influencing airborne allergens and
pollutant levels. Decrease in air temperature represents an
aggravating factor of asthmatic symptoms, regardless of
geo-climatic areas under study; furthermore, studies based
on synoptic method (a categorization of daily weather into
air mass types, which are homogeneous bodies of air with
distinct thermal and moisture characteristics) supported
findings derived from analyses with only air temperature as
a meteorological variable. The influence of cold on airway
obstruction in asthmatics is used systematically in the cold-
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Table 4 Key Statements in the WAO White Book on Allergy,
Update 2013, World Allergy Organization 2014, page 16.
Reprinted with permission from the editors [159]
Climate Change, Migration and Allergy
The earth’s temperature is increasing as illustrated by rising sea levels,
glaciers melting, warming of the oceans and diminished snow cover in
the northern hemisphere.
Climate change coupled with air pollutant exposures may have
potentially serious adverse consequences especially for human health in
urban and polluted regions.
High summer temperatures have an impact on rates of acute
exacerbation and hospital admission for elderly patients with breathing
problems and may cause unexpected death.
Pollen allergy is frequently used to study the interrelationship between
air pollution and respiratory allergy. Climatic factors (temperature, wind
speed, humidity, thunderstorms, etc.) can affect both biological and
chemical components of this interaction.
Changes in the weather such as thunderstorms during pollen seasons
may induce hydration of pollen grains and their fragmentation which
generates atmospheric biological aerosols carrying allergens (see also
sections on thunderstorms and sandstorms in this document). As a
consequence asthma outbreaks can be observed in pollinosis patients.
Migration from one country to another involves exposure to a new set
of pollutants and allergens as well as changes in housing conditions,
diet and accessibility to medical services which may affect migrants’
health.
Atopy and asthma are more prevalent in developed and industrialized
countries compared with undeveloped and less affluent countries.
Migration studies provide information on the role of environmental
factors on the development of atopy and asthma.
Physicians should be aware that environmental and climate changes
may enhance the development of allergic diseases and asthma.
Physicians should be aware that migrants, especially from developing to
more developed countries, are at increased risk to acquire allergic
diseases and asthma and that the effect is age and time-dependent.
Earlier age and longer time increase the likelihood of developing atopy
and asthma.

provocation test for measuring the severity of non-specific
nasal and bronchial hyperreactivity [160–162].
While results on effects of cold air on asthma are consistent, the role of humidity, wind, and rainfall is still unclear,
and studies including these variables showed inconclusive
and inconsistent results. Conversely, a prospective study
from New Zealand has not shown any statistical significant
association between meteorological variables and symptoms of asthma daily recorded in a diary [148].

What might be the effects of climate change on
respiratory allergy?

In the light of current knowledge, air pollution and aeroallergens seem critical in evaluating the possible effects
of climate change on allergic respiratory diseases. An increasing body of evidence suggests that climate change
might affect both environmental factors.
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How does climate change influence air pollution type and levels?

Climate change may affect air pollutant levels in several
ways: the influence on regional weather (changes of wind
patterns and amount and intensity of precipitation, increase of temperature) may have an effect on severity and
frequency of air pollution episodes and also on anthropogenic emissions (for example, increase of energy demand
for space heating or cooling); the enhancement of the
urban heat island effect may increase some secondary pollutants (i.e., ozone), and it can indirectly increase natural
sources of air pollutant emissions (e.g., decomposition of
vegetation, soil erosion, and wildfires) [163–168].
Tropospheric ozone (O3) is formed in the presence of
bright sunshine and high temperatures by the reaction
between volatile organic compounds (VOC) and nitrogen
oxides (NOx), both emitted from natural and anthropogenic sources. An association between tropospheric ozone
concentrations and temperature has been demonstrated
from measurements in outdoor smog chambers and from
measurements in ambient air, even if it does not occur
when the ratio of VOC to NOx is low. Tropospheric
ozone concentrations are increasing in most regions, and
this trend is expected to continue over the next 50 years.
Pollen from birch exposed to higher ozone-levels induce
larger wheals and flares in skin prick test compared to
lower ozone-exposed pollen suggesting an allergenicityincreasing effect of ozone [169].
Changes in temperature and precipitation may also increase frequency and severity of forest fires, sometimes with
public health consequences. Changes in wind patterns may
increase episodes of long distance transport of pollutants as
well as of pollen grains, making large-scale circulation patterns as important as regional ones [167, 168, 170].
Climate change appears to induce an increased concentration of all health-related air pollutants. Of particular
concern are potential changes in tropospheric ozone and
particulate matter. However, the consequence of higher
temperature on ozone concentration might be partially
counterbalanced by a decrease in demand of heating systems during mild winter due to global warming. Prediction about the effects of climate change on health-related
air pollution is hampered by several limits: future emissions depend on numerous factors, such as population
growth, economic development, energy use and production; current knowledge about weather effects on air
pollution is still unsatisfactory; there is still a need of
better emission inventories and observational datasets;
and long-term effects and actual enforcement of international agreements to reduce air pollution and greenhouse
gases emissions (e.g., Kyoto protocol) are unpredictable.
How does climate change influence allergenic pollen?

Plant species require a certain amount of heat to complete
their development; then air temperature plays a key role,
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together with other factors, such as day-length, water and
nutrient availability, and soil type. Increasing worldwide
evidence demonstrates that the timing of life cycle events
of a large number of species have responded to the increase
in Earth’s temperature. Changes involve also plants producing allergenic pollen, with expected consequences
on atopic populations [70, 170–173]. Data provided by
30 years of observations within the International Phenological Gardens network showed that spring events advanced by six days, the highest rate of phenological
changes observed in the Western Europe and Baltic regions [174]. Conversely, phenological trends appear to
be different in the eastern border of Europe, sometimes
showing 1–2 weeks later in the start of the phases. An
earlier start of the season was confirmed in studies focused
on allergenic plants, as birch, mugworth (Urticaceae, grass
and Japanese cedar), even if different methods and different
lengths of datasets have been used. Due to the earlier onset,
the pollen seasons are more often interrupted by adverse
weather conditions in late winter/early spring [70, 174–181].
Duration of the pollen season is also extended, especially
in summer and in late flowering species. Moreover, there
is some evidence of significantly stronger allergenicity in
pollen from trees growing at increased temperatures.
Increasing CO2 and temperature seem to substantially
increase pollen production from ragweed in experimental
conditions. The same results were obtained in a study on
ragweed plants growing in urban and rural areas, providing an elegant “natural” model for evaluating possible effects of global warming. In this study, Ziska et al., showed
that Amb 1 concentration in ragweed pollen increased as
a function of CO2 concentration. The difference in Amb 1
as a result of increased CO2 may be affected also by influences among and within different ragweed populations
[175]. The observed long-term changes in the large-scale
atmospheric circulation have an impact on wind patterns.
These changes may increase the long distance transport of
allergenic pollen into less affected areas, as shown with
the detection of ragweed in central Italy [170].
However, other factors might modify the distribution
of allergenic plants in Europe. The cases of grass and
ragweed are explanatory. Grass pollen is responsible for
a high percentage of pollinosis worldwide, and variations
in total pollen count have been observed in the last decades. The analysis of the time series of aerobiological data
from the United Kingdom, the longest of the world,
showed a decreasing trend in terms of yearly grass pollen
counts and severity of pollen season and an earlier start of
the season. However there are remarkable differences
between the three study sites – Cardiff, London, and
Derby, underlining the role of local determinants (such
as climate), plant adaptation (i.e., tolerance to environmental factors), changes in land use, and changes in species and
effects of air pollutants [165].
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Since the last decades of the nineteenth century, ragweed
has been increasingly important from an allergological
point of view, covering large areas of Central and Eastern
Europe. In the eastern countries the expansion of ragweed
seems to be associated with major socio-economic transitions rather than with climate change [177–181].
Recent analysis of a continental-scale pollen data set
reveals an increasing trend in the yearly amount of airborne
pollen for many but not all taxa in Europe, which is more
pronounced in urban rather than semi-rural/rural areas.
Climate change may contribute to these changes; however,
increased temperatures do not appear to be a major influencing factor. Instead, we suggest the anthropogenic rise of
atmospheric CO2 levels may be influential [182].
Overall effects on respiratory allergy

Several factors make a prediction very challenging in this
field. Firstly, climate change scenarios are based on mathematical models, which contain some limits. Since little
increases in Earth’s temperature seem to have a dramatic
effect on living organisms, little differences in the magnitude of global warming might substantially change our
previsions on the effects on human health. Moreover, predictions appear to be more accurate on a regional than
global scale, since local factors play a key role in determining the effects of climate change.
Secondly, changes in health-related air pollutants levels
are strictly dependent on future emission scenarios, which
are based on economic and demographic projections. A
further limit lies in the difficult-to-predict actual enforcement of international agreements to reduce emissions.
Thirdly, even if an increasing number of observations
show that climate change is affecting all phases of plant
development, there are still uncertainties about the effects
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on start, length, and end of the pollen season of allergenic
plants. The numerous papers published on this topic
showed the effects to be different for each plant and geographical area under study, biological and socioeconomic
factors playing also a role [70, 78, 139–143]. Only a few experimental studies reported an increase in pollen allergenicity in CO2 enriched environment, suggesting this should
be a key topic for further research over the next decade.
Finally, trends of worldwide asthma prevalence are still
unclear, being different in developing and in industrialized
countries. Epidemiologic studies show that air pollution
has a negative effect on lung development, potentially
explaining the association of pollution on the greater
prevalence of asthma in urban environments [70, 159,
175–179, 182, 183]. The influence of climate change on
symptoms of respiratory allergy is still unpredictable.
Two opposite effects could be relevant. On one hand,
global warming could increase length and severity of
pollen season and, as a consequence, of pollen allergy.
Moreover, the increase in occurrence of heavy precipitation
events, as predicted by recent climate change scenarios,
could make episodes of asthma epidemics more frequent.
Finally, overall effects on health-related air pollutants seem
favorable to an increase of urban air pollution episodes. On
the other hand, increase of Earth’s temperature could
reduce the effects of cold air on asthma and rhinitis,
also making patients less susceptible to upper respiratory infections (Fig. 3).
Conclusions

Pollen allergy is frequently used to study the interrelationship between air pollution and respiratory allergy. Climatic
factors (temperature, wind speed, humidity, and thunderstorms, etc.) can affect both components (biological and

Fig. 3 Possible effects of climate change on respiratory allergy. Source: Lorenzo Cecchi, original drawing
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chemical) of this interaction. By attaching to the surface of
pollen grains and of plant-derived particles of paucimicronic size, components of air pollution could modify not
only the morphology of these allergen-carrying agents but
also their allergenic potential. In addition, by inducing airway inflammation, which increases airway permeability,
pollutants overcome the mucosal barrier and could be
able to “prime” allergen-induced responses.
Much remains to be studied by using biologic, genetic,
epidemiologic and clinical approaches to air pollution.
However, public health approaches to decrease exposure
of citizens to air pollution must be implemented considering that the following goals should be reached:
 Reducing use of fossil fuels and controlling vehicle

emissions
 Reducing the private traffic in towns improving the

public transport and favoring pedestrian traffic
 Planting non-allergenic trees in cities [183].

As for the last point, it is important to consider that
unfortunately each year a lot of hectares of woods are
destroyed by prevalent fires, frequently criminally intentional.
Of course, these fires and the reduced woods are responsible
for the reduction of living trees. Moreover, although there is
no general agreement, increasing the antioxidant defenses of
the human airways by eating antioxidant foods should be
implemented.
Governments worldwide and international organizations
such as the World Health Organization and European
Union are facing a growing problem of the respiratory
effects induced by gaseous and particulate pollutants
arising from motor vehicle emissions. The last release
of the Intergovernmental Panel on Climate Change (IPCC)
stated that climate change is very likely due to human
activity, according to an impressive amount of data
published in the last years, and policymakers seem now
to take into greater consideration preventive measures
(such as the Kyoto Protocol) and alternative energy
sources. Desirable positive effects of these measures
may be achieved in the next decades but, presumably,
global temperature will continue to increase in a shortterm perspective.

Pollen allergy and meteorological factors
Introduction

Pollen grains, a causative agent of asthma and rhinitis,
are among the commonest allergens in atopic patients.
Pollen allergy is now a public health problem due to its
elevated prevalence and associated costs [70] in terms of
impaired work fitness, sick leave, and cost of healthcare
[159]. In the European Union countries between 8 and
35 % of young adults show IgE serum antibodies to grass
pollen allergens that are the most commonly encountered
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[71]. Major pollens involved in rhinitis and asthma besides
grass include birch primarily in northern countries and
ragweed in east-central Europe. In southern countries
Parietaria (wall pellitory) and cypress play an important
role as well.
Pollen and weather monitoring

Weather conditions, including rainfall, atmospheric
temperature, humidity, wind speed, and wind direction, may alter the concentrations of plant pollens and
other allergens, which can subsequently influence the
occurrence of allergic diseases such as asthma, allergic
rhinitis, allergic conjunctivitis, and even atopic dermatitis
[155, 184–188]. Many studies have demonstrated that CO2
concentration and increased atmospheric temperature
increase pollen concentration [189].
Most work on the impacts of climate change on aeroallergens can be divided into a number of distinct areas,
including impacts on pollen amount, pollen allergenicity,
pollen season, plants, and pollen distribution. Metrological factors such as mean temperature, wind speed,
humidity, amount of sunlight, and degree-days can directly affect biological and chemical components of this
interaction [190, 191].
The accumulation of daily sunshine, and other impacting meteorology factors such as humidity and precipitation, should be taken into consideration to further improve
the accuracy of the modelled start dates and season lengths
of birch and oak pollen and develop regression models for
pollen prediction. Daily fluctuations in the amount of
pollen have to do with a variety of meteorological factors
such as temperature, rainfall, and the duration of sunshine.
Temperature and rainfall are especially important in
determining pollen concentrations, but the relationship
is complex and influenced by other variables. At least
10 weather elements that are thought to affect the concentration of pollen are used to develop equations for
the pollen forecasts. The elements are: daily mean
temperature, rainfall, average wind speed, relative humidity, maximum temperature, minimum temperature,
temperature range, continued rainfall hours, accumulated
sunshine hours, and accumulated mean temperature. Predictive equations for each pollen species and month are
developed based on statistical analyses using observed
data with 10 weather elements during the last several
years in some countries. Although few observations and
estimates were reported regarding season start and length
of allergic pollens in the other countries, earlier start dates
and rising pollen concentrations have been reported
widely in many European countries [192, 193].
The growing degree hour (GDH) model was used to
establish a relationship between start and end dates of
pollen production and differential temperature sums
using observed hourly temperatures from surrounding
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meteorology stations. Studies of climate change effects
on distributions of allergenic pollens have focused typically on analysis of observed airborne pollen counts and
their regression relationships with local meteorological
and climatic factors. Observed airborne pollen data for
pollen collecting stations at locations representing a
wide range of geographic and climatic conditions should
be analyzed statistically to identify the trends of start
date, season length, and annual mean and peak value of
daily concentrations of allergic pollen [194].
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Pollen season, that is the period during which pollen is
present in the air, is related to the flowering season, for
pollen has to be previously produced and emitted by mature flowers. Pollen seasons and flowering seasons usually
do not fully coincide because of the effects of mid- and/or
long-range transport. The onset, duration and intensity
(i.e. abundance of pollen grains in the air) of the pollen
season vary from year to year. Weather variables, mainly
air temperature, sunlight and rainfall together with CO2
are among the main factors affecting phenology (that
means the times of the appearance of first leaves, first
flowers, autumn leaf coloration, and so on) and pollen
production by plant. In addition, weather patterns influence the movement and dispersion of all aeroallergens in
the atmosphere through the action of winds and rainfall
and depending on the atmospheric stability [195].
The effect of temperature is greater on the spring and
early summer flowering plants whereas species that
flower in late summer and fall generally are correlated
with photo period. Thus, the former species are more affected by warmer winters and springs, showing an earlier
flowering in the last two decades [196].
The complex relationship between weather, climate and
concentration of pollen in the atmosphere play a key role
on the allergen level. In order to reduce the exposure to
pollen and to improve the measures listed earlier, it is
therefore crucial to provide patients with a reliable aerobiological forecast. Although the quality of weather forecast
improved substantially in the last decades, effects of weather variables on aeroallergen load are not completely
understood. For instance, rainfall clears the air from pollen,
thus reducing the risk of exacerbation of rhinitis and/or
asthma; extreme rainfall events, like thunderstorms,
are, however, associated with severe/near fatal asthma
epidemics [81]. A deeper understanding of the relationship between weather and pollen concentration is the first
step for the development of a reliable pollen forecast, useful in preventing pollen dependent allergic symptoms.

This dramatic change prompted a new way to look at the
mechanisms linking exposure, sensitization and symptoms
of respiratory allergic diseases, involving aerobiology
[197]. Although the pollen count has been used for over
50 years for the assessment of allergen exposure both in
clinical practice and experimental studies, proof is lacking
that pollen count is representative for allergen exposure.
In this context, measurement of the allergen content of
pollen, the so called pollen potency, might contribute to
improve our knowledge on the relationship between exposure to airborne allergens and allergic sensitization
and symptoms. After the early studies at the end of the
twentieth century [198, 199] a number of papers have
been published in the last few years in Germany and
Spain [200–205] utilizing improved sampling devices and
methods of analysis [206].
More recently, the HIALINE (Health Impacts of airborne
ALergen Information Network) (www.hialine.eu) project
funded by the European Union set the standard for the
assessment of pollen potency in ten countries over three
pollen seasons. Measurement of Phl p 5, Ole e 1 [207] and
Bet v 1 [208] in the pollen of grass, olive tree, and birch respectively confirmed that the allergen count deviates from
pollen count. These findings imply that potency of pollen is
variable, even on a daily basis, and that number of pollen
might not best represent allergen exposure.
Both climate and weather play a key role in the production, release and bioavailability of pollen-derived allergens.
The explanation why pollen vary in their potency is that
the allergens are synthesized in pollen during ripening of
the pollen. In the week before pollination, no allergen was
found in pollen, which otherwise were ready to release.
Subsequently, a rapid increase in allergen content of the
pollen occurred. At the same time, the anthers developed.
Anthers react to weather conditions, and when conditions
are good for pollination (ripe anthers, low humidity and
warm enough) they open and release pollen. If the weather conditions are favorable for early pollination, ripe anthers will release less ripe pollen with less allergen.
Otherwise, when weather is such that anthers do not open
until later, riper pollen with more allergen is released
[201]. The meteorological factors that control allergen ripening are not yet clear, as studies performed so far compared weather condition around the pollen trap with the
potency or amount of detected pollen. This assumes that
the detected pollen stem from plants that live in the area
for which the temperature is recorded. However, pollen
travel longer distances and the weather condition at the
source [209], i.e., at the place of pollination, must be correlated with pollen potency. This has not been done.

Effects of weather on allergen load and pollen potency

Advice and tips for reducing exposure to pollen

In the last 10 years allergology has changed dramatically,
moving from the extracts to a molecular-based diagnosis.

Patients should recognize their allergy symptoms and if
they still have not received a diagnosis should seek necessary

Effects of weather on pollen release/flight
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medical help, preferably from a knowledgeable physician. It
is important to be aware of both the pollens to which a patient is exposed and those to which the patient is sensitized.
The patients sensitized to pollens should read their
regional pollen bulletins to keep themselves properly up-todate on allergic disease prevention and treatment. This allows them to associate their symptoms to the pollen they
are allergic to, understand the disease better and consequently treat it more efficiently. While knowledge of allergic
disease is becoming more widespread, it is noted that many
allergic patients are underdiagnosed and undertreated.
After diagnosis, the patient ideally should be treated prior
to or at the beginning of the seasonal period to minimize
the severity of the disease. Usually oral anti-histamine medication or/and nasal steroids can help and reduce symptoms,
mainly on those suffering of allergic rhinitis. This should be
adapted on a case-by-case basis in line with the symptoms
in question and always following the physician's instructions. Certain pollen-allergy patients can benefit from taking
anti-allergic vaccines, which are very effective if used appropriately and under the strict supervision of a knowledgeable
physician. Taking these vaccines can change the course of
the allergic disease which can provide primary prevention
of more severe signs, such as asthma.
In addition to pharmacological treatment, the other
element necessary for the control of an allergic disease is
to avoid exposure to the allergens to which the individual is sensitized. Unfortunately, in the case of pollen allergy, an effective and total avoidance is not possible.
However, patients sensitized to pollens, suffering from
allergic rhinitis, rhino-conjunctivitis, or asthma, can take
several measures to provide protection against or to
minimize the symptoms. These are as follows:
 Know the times of the year when pollen is most

likely to be a problem
 Try to stay indoors when the wind speed is high
 Reduce outdoor activity, especially in high

pollination areas
 Avoid outdoor sports or camping
 Avoid walking in large grassy areas or mowing the grass
 Keep the windows closed when the pollen counts are

high, particularly on hot and dry days with strong winds
 Use high-strength particle filters in cars and driving

with the windows closed
 Cyclists and motards use closed-visor helmets
 Wear dark glasses outdoors
 Change clothes and take shower after extended

outdoor activity during high pollen production time.
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and respiratory symptoms and asthma [210]. Indoor dampness may not only aggravate pre-existing respiratory conditions, but there is also (limited) evidence that it may cause
new onset symptoms and asthma [211]. It may also increase the risk of respiratory infections [212] and depression [213] which in turn may increase the risk of
respiratory symptoms and asthma [214, 215].
Estimates from several European countries, the United
States of America, and Canada suggest that at least 20 %
of buildings have one or more signs of problems with
dampness [216]. These estimates are mostly based on
self-reports of leaks, floods, wet basements, window condensation, visible fungal growth, or moldy odors. Based on
several studies conducted in the United States of America,
Mudarri and Fisk estimated the prevalence of dampness
and/or fungi in US houses to be as high as 50 % [217]. A
2011 World Health Organization report estimated that in
cold climates 15 % of dwellings have signs of dampness
problems in general, and 5 % have signs of mold problems
[218]. In warm climates the corresponding estimates were
20 % for dampness and 25 % for mold. The estimate for
water damage was 10 %, regardless of climate. Since
dampness is more likely to occur in houses that are overcrowded and lack appropriate heating, ventilation, and
insulation [210], the prevalence of damp indoor problems
in low-income communities and rental accommodation
scan be substantially higher than the national average.
Thus, a substantial proportion of the population is
currently at risk of experiencing adverse health effects
associated with damp indoor environments. Climate
change and its effects on the weather (i.e., storms and
heavy rain fall) and the subsequent rise in sea levels and
increased frequency and duration of floods are likely to
further increase the proportion of buildings with damp
problems, and exacerbate the defects in buildings that
are already leaking, particularly in flood-prone areas
such as river valleys and coastal areas. In addition, the
high energy costs may prevent adequate heating in winter in many homes (fuel poverty) leading to increased
risk of condensation and indoor dampness. Climate
change through increased temperatures and humidity
may also increase the atmospheric concentration of fungal spores combined with an earlier seasonal start and
increased allergenicity further increasing the risk of allergies and asthma [188].
In this section, we discuss the respiratory health effects
associated with damp and mold-affected indoor environments and the impact climate change may have on exposure
to mold and dampness, and associated effects on asthma.

Molds, rain, humidity, dampness

Health effects of indoor dampness

Introduction

A consistent association between home dampness and
respiratory symptoms and asthma has been observed in
a large number of studies conducted across many geographical

There is a cumulative body of evidence demonstrating a
highly consistent association between home dampness
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regions [210, 211]. Positive associations have shown up
in infants [219], children [220] and adults [221], and
there are demonstrations of some evidence for dose–response relationships [210, 211, 222]. Based on a comprehensive literature review up to July 1998, Bornehag et al.,
concluded that indoor dampness “appears to increase the
risk for health effects in the airways, such as cough,
wheeze and asthma” [223]. The risk was estimated to be
1.4–2.2 fold compared to those not living in damp homes.
The authors also suggested an association between dampness and other symptoms such as tiredness, headache, and
airways infections. A review by the Institute of Medicine
confirmed this picture and stated that there was sufficient
evidence of an association between indoor dampness and
upper respiratory (nasal and throat) tract symptoms,
cough, wheeze, and asthma symptoms in sensitized persons [210]. However, the report noted that there was insufficient evidence to conclude that the association was
causal. A more recent review including publications up to
the end of 2009 confirmed this but commented that the
evidence for an association with asthma exacerbation was
now strongly suggestive of being causal [211]. Fisk et al.,
in another recent review concluded that “building dampness and mold are associated with approximately 30–50 %
increases in a variety of respiratory and asthma-related
health outcomes” [217]. A recent formal meta-analysis including studies published from 1980 to 2010 showed that
visible mold was positively associated with asthma (OR 1.49
(95 % CI 1.28-1.72), wheeze (OR 1.68 (95 % CI 1.48-1.90)
and allergic rhinitis (OR 1.39 (95 % CI 1.28-1.51) [224].
Only a few experimental intervention studies (in subjects with respiratory symptoms) have been conducted
and these showed reductions in asthma exacerbations,
acute care visits, self-reported poor health, wheeze, school
and work absenteeism when compared to control groups
[211]. Of particular interest is a study by Kercsmar et al.,
who conducted a controlled experimental intervention
study in houses of highly symptomatic children [225]. Removal of the sources of dampness and mold caused a substantial and statistically significant reduction in asthma
exacerbations. Also, acute care visits at 6–12 months after
intervention were 90 % fewer in the remediation group
when compared to the control group.
Although a causal association between dampness and
respiratory morbidity has been suggested by some authors [223], it is based mainly on cross-sectional studies
and prevalence case–control studies. Therefore it is not
clear whether indoor dampness causes only exacerbates
pre-existing respiratory conditions such as asthma. Longitudinal and incident case–control studies are better
suited to assess this; however, only few of these studies
have been conducted. Three longitudinal studies following babies from birth showed that indicators of home
dampness were associated with an increased risk of
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asthma symptoms in the first 1 or 2 years of life [211].
These studies must be interpreted in light of the difficulty in diagnosing asthma in infants. Two other prospective studies in older children (1–13 years) confirmed
that exposure to indoor dampness was associated with
the subsequent development of asthma [211]. These
studies showed that dampness increased the risk of new
onset asthma by a factor of approximately 2.5. Also, a
longitudinal study in 6443 adults showed that building
dampness (measured either as water leakage or damp
spots), but not visible mold was associated with accelerated lung function decline in women [226]. Although
these results require confirmation, they do suggest that
in addition to new onset asthma, dampness may also
cause a decline in lung function.
In addition to non-infectious respiratory symptoms,
there are also a number of studies in children and adults,
suggesting an association between indoor dampness and
respiratory infections [212]. These studies included two
prospective studies in children showing that dampness increased the risk by a factor of 1.3–5.1 [212]. As respiratory
infections particularly in early life are associated with asthma
development this may further increase the risk of asthma
[214]. Likewise, flooding and indoor mold and dampness
are associated with adverse effects on mental health [213]
which in turn may increase the risk of asthma [215].

Indoor exposures associated with indoor dampness

The causal exposures associated with dampness and adverse health effects have not been conclusively determined, but a critical role for bioaerosols (most notably
mold and bacteria) is plausible [211]. Bioaerosols are
generally found in elevated concentrations in the air in
damp and poorly ventilated buildings. There are a broad
range of bioaerosols relevant to damp indoor environments, which include fungi (especially molds and yeasts),
fungal spores, hyphae, as well as fungal fragments and
allergens; bacteria and bacterial spores; microbial toxins
and pro-inflammatory components, such as mycotoxins,
ergosterols, β 1 → 3-D glucans and endotoxins; mite allergens; algae; amoebae; and viruses. In addition to
bioaerosols, indoor dampness may result in elevated
concentrations of fungal volatile organic components as
well as increased chemical emissions of building materials and floor covers. The interest in bioaerosol exposure has increased in more recent times, in particular
due the global increase in allergies and asthma. However, despite the recognition of the importance of
bioaerosols, the precise role of these agents in the induction, aggravation and progression of asthma (and
other respiratory symptoms) is only poorly understood.
Although other bioaerosols may also play a role, the
specific focus of this section is on molds.
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Asthma burden due to indoor dampness and mold

As noted above, climate change and its effects on the
weather (i.e., frequent storms and heavy rainfall) and the
rise in sea levels and the subsequent increased frequency
and duration of floods will likely affect the number of
buildings with damp and mold problems and exacerbate
the defects in buildings that are already leaking. However, the magnitude of the increase of houses affected by
dampness and mold and their effects on respiratory
health is still unclear, in part because studies evaluating
the effect on indoor mold concentrations and respiratory
symptoms due to flooding or water damage following severe storms are rare. The best data available are from
studies assessing mold exposure and health effects following hurricanes Katrina and Rita in the United States
of America. These studies showed increased fungal
growth in houses that were moderately to severely affected, and there was some suggestion that the composition of the microflora also changed after the hurricanes
[230]. Subsequent studies in homes with limited flood
damage and with a large proportion of homes having
undergone renovation work showed low levels of indoor
mold spores and no differences were found between
flooded and non-flooded houses [231]. Workers involved
in renovation work immediately after the hurricanes
were exposed to increased levels of bacterial and fungal
agents, but levels markedly decreased within the first
year after the hurricanes [232]. These studies suggest
that increased exposure to mold following a flooding is
likely, but exposure levels may return back to normal
over time (at least in part due to renovation work conducted during this time). The benefits from this are diminished by the increased likelihood that subsequent
flooding is more likely to occur due to climate change.
The effects on asthma are not clear with some reports
suggesting an increased risk of respiratory symptoms in
home occupants [233] and renovation workers [234],
and others showing no association [235].
It is clear that climate and weather have an effect on
atmospheric molds, both in terms of number of spores
and species [236]; however, only few studies have studied
the impact of climate change. A study from New England
(United States of America) showed both an earlier seasonal start (by 2–4 weeks) of atmospheric mold spores
and higher spore counts following an El Niño event [237].
Corden and Millington examined long-term (1970–1998)
trends of Alternaria spore concentrations in Derby
(United Kingdom) and showed that spore concentrations
increased with increases in local temperature [238]. A
similar association was found with earlier start and increased duration of the spore season. Interestingly, there
is also experimental evidence showing that Alternaria
alternata grown at increased CO2 levels produced almost
three times more spores and more than twice the total
antigenic protein [239]. These studies provide (limited)

A 2011 World Health Organization report has shown that
a considerable proportion of childhood asthma cases is attributable to exposure to indoor dampness and mold
[218]. Based on data for 45 countries of the European region, it was estimated that 0.07 asthma-related deaths and
50 asthma-related disability-adjusted life years (DALYs)
per 100,000 children per year are associated with exposure
to dampness in dwellings, and that 0.06 deaths and 40
DALYs per 100,000 children per year are associated with
exposure to mold [218]. These two environmental burden
of disease assessments overlap, as damp indoor conditions
are a prerequisite for microbial growth. As noted above,
the burden appears to be highest in low-income communities often relying on poorly heated and maintained
rental accommodation. Adults with current asthma
were more likely to be black and to live in households
that were <100 % federal poverty line (FPL) [226, 227].
Atmospheric mold exposures and asthma

Outdoor exposure to fungal spores of Alternaria and Cladosporium has been associated with atopic sensitization
and asthma, with the strongest evidence for asthma exacerbations. In particular, several studies in children and
adults have shown that increases in atmospheric fungal
spore counts were associated with significantly more
asthma admissions and emergency visits [228, 229].
Similarly, positive associations have been observed for
asthma symptoms, asthma medication use, and peak
flow variability [229], although results have not always
been consistent with some studies finding no associations
[229]. There is also evidence that increased atmospheric
mold spore concentrations may play a role in thunderstorm asthma, a phenomenon characterized by a sharp increase in asthma hospital emergency visits following
thunderstorms. In particular, a Canadian study found that
fungal spore counts doubled and pediatric asthma emergency admissions increased by more than 15 % on days
with thunderstorms while no increases were found in the
concentration of pollens and other air pollutants [83].
These studies suggest that, in addition to indoor sources
of mold, atmospheric mold may also be a risk factor for
asthma (exacerbations).
The effects of climate change on dampness and indoor
and ambient mold exposures

The impact of climate change on dampness and indoor
and outdoor mold has received little attention in comparison to other aeroallergens such as pollens. Nonetheless,
there is some evidence that climate change may increase
the prevalence and severity of dampness and indoor
and atmospheric mold exposures which we will briefly
summarize below.
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evidence that climate change may affect the atmospheric concentration of fungal spores and start and
duration of spore seasons as well as the allergenicity of
fungal spores, potentially increasing the risk of allergies
and asthma.
Adaptation measures to reduce the impact of climate
change on indoor dampness and mold

Optimal prevention involves measures to reduce greenhouse gases. However, in the meantime adaptation measures are essential to minimize the effects of climate change
on indoor dampness and its associated respiratory health
burden. These may involve a range of legislative and
specific building design and construction measures to
minimize the risks of leaks and surface flooding including:
modification of regulations and building codes to better
protect residential and commercial buildings from severe
weather events and more stringent enforcement of existing and new regulations and building codes; restriction of
building construction in flood-prone areas such as lowlying coastal and river areas; creation of incentives to improve existing housing stock; improvement of control of
rain and surface water through appropriate drainage including drainage of the building foundations; restriction of
the use of flat roofs and installation of eaves to protect
walls from getting wet from rain water; the utilization of
appropriate methods to ensure that buildings are watertight; installation of appropriate ventilation including in
attic and crawl spaces to reduce the effects of indoor
dampness; and installation of vapor barriers in walls. The
effects of inadequate heating in winter due to fuel poverty
(leading to increased risk of condensation and indoor
dampness and respiratory symptoms) may be partially
mitigated by the creation of incentives to introduce more
fuel efficient heating sources (which in turn would contribute to lower green-house gas emissions). Nonetheless,
even if adaptation measures are taken then some flooding
and/or rain damage will be inevitable. In those cases the
effects of flooding and leaks on indoor dampness and microbial growth can be minimized by early and adequate
building repairs avoiding more serious problems and reducing the risk of subsequent respiratory morbidity.
Conclusions

There is strong evidence of an association between indoor dampness and a wide range of respiratory symptoms including asthma. In addition to exacerbation of
pre-existing asthma, there is (limited) evidence that indoor dampness may cause new onset asthma. Indoor
dampness and flooding may also indirectly be a risk factor for asthma through increased infections and mental
health problems. Climate change and its effects on the
weather (i.e., storms and heavy rainfall), the subsequent
rise in sea levels and increased frequency and duration
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of floods, and the concurrent increase in fuel poverty
will likely contribute to a higher proportion of buildings
with excessive dampness. This may lead to increased risk
of allergies and asthma of home occupants. Although
the evidence is currently limited, climate change through
increased temperatures and humidity may also increase
the atmospheric concentration of fungal spores, which
combined with an earlier seasonal start and increased allergenicity of fungal spores may further increase the risk
of allergies and asthma and increase the overall disease
burden of allergic diseases and asthma. However, the
evidence is currently still limited and the magnitude of
these effects is unclear.

Allergy and asthma in the tropics
For many years, most of the information and research in
the field of allergy came from developed countries in
both the northern and southern hemispheres. In contrast, knowledge about allergies and asthma in low and
middle income countries in the tropical areas is relatively low; nonetheless, more insights on the burden,
triggers, and management of these have increased over
the last decades.
The Tropics is a very dynamic region surrounding the
Equator with a vast biodiversity and climatic variability,
ranging from warm to hot and moist year-round. Tropical rainforests have their rainfall equally distributed
throughout the year. In addition, climate change could
have a big impact on the region, having an influence not
only on the climate of the Tropics by itself but also on
its biodiversity. The northern limit of the Tropics is the
Tropic of Cancer, whereas the limit in the southern
hemisphere is the Tropic of Capricorn (23 ° 26’ 16” north
and 23 ° 26′ 16″ south, respectively). The Tropics is also
called the tropical zone or the Torrid Zone due to very hot
usually dry temperatures. All twelve months have mean
temperatures above 18 °C (64 °F). In the Tropics the sun’s
rays are hitting the planet exactly perpendicular to its surface. The Tropics has clear distinguishable features from
the other climatic and biomatic regions of the Earth, the
middle latitudes, and the Polar Regions on either side of
the equatorial zone. Therefore, different environmental
factors, such as infections (e.g., parasitic infections), type
and duration of allergen exposure, and disease expression
can be found in patients from the tropical zones as
compared to those from the other parts of the globe. In
general, allergic diseases and asthma are underdiagnosed
and undertreated, and since most of the tropical countries
are non-affluent, many patients with allergies and asthma
do not have access to appropriate diagnosis, care, and
medications, or else they can hardly afford the cost of
medications. Whereas the burden of allergic diseases
and associated diseases has increased, the number of
healthcare professionals trained in the diagnosis and
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treatment of allergy are very few in proportion. As a
result, a large number of patients are undiagnosed or
undertreated. While many developing countries have
few or no allergy-trained physicians to treat millions
of allergy and asthma sufferers, even in developed
countries, many highly sophisticated areas have a
shortage of allergists [240].
Africa

The International Study of Asthma and Allergy in
Childhood (ISAAC) series provided new information
concerning the prevalence of asthma, allergic rhinitis, and
eczema in tropical countries. In Africa and as a part of
the ISAAC Phase I study, only six African countries were
involved (Algeria, Tunisia, Morocco, Kenya, South Africa,
and Ethiopia), three of them located in the Tropics
(Kenya, Ethiopia, and South Africa). Phase III, conducted
5–6 years later, enrolled 22 centers in 16 countries including the majority of the centers involved in Phase I and
new centers in Morocco, Tunisia, Democratic Republic of
Congo, Togo, Sudan, Cameroon, Gabon, Reunion Island,
and South Africa (6 out of 16 belong to the tropical zone).
There were considerable variations between the various
centers in Africa on the prevalence of the main symptoms
of the three conditions: wheeze (4.0–21.5 %), allergic rhinoconjunctivitis (7.2–27.3 %) and eczema (4.7–23.0 %).
There was also a large variation between countries and between centers within the same country. Several centers,
including Cape Town (20.3 %), Polokwane (18.0 %),
Reunion Island (21.5 %), Brazzaville (19.9 %), Nairobi
(18.0 %), Urban Ivory Coast (19.3 %) and Conakry
(18.6 %), showed a relatively high asthma symptom prevalence, similar to those in Western Europe. There were also
a number of centers showing high symptom prevalence
for allergic rhinoconjunctivitis (Cape Town, Reunion
Island, Brazzaville, Eldoret [Kenya], Urban Ivory Coast,
Conakry, Casablanca, Wilays of Algiers, and Sousse) and
eczema (Brazzaville, Eldoret, Addis Ababa, Urban Ivory
Coast, Conakry, Marrakech, and Casablanca). In Africa,
13 countries located in the tropical area took part of the
ISAAC Phase III Survey [241].
There is evidence that asthma is increasing in prevalence and severity in Africa. The ISAAC study has shown
that there is also an increase in the prevalence of allergic
rhinitis and eczema. Despite the fact that previous studies
have suggested that the prevalence of atopy in West Africa
is low, more recently it has been shown that allergic
sensitization to house dust mite and other allergens such
as cockroach are risk factors associated with asthma in
Ghana [242]. As in other parts of the world the upward
trend in allergic diseases has been associated with an increase in urbanization; the increased urbanization and
change in lifestyles in the Tropics are possible among the
factors associated with the increase in the prevalence of
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allergy and asthma. In the urban population in Ethiopia,
Dermatophagoides pteronyssinus skin sensitization was a
risk factor related to wheeze and was stronger than in the
rural areas. D.pteronyssinus sensitization was common in
rural areas but was not a risk factor for wheezing, possibly
due to the high prevalence of parasitic infections in these
areas. This study suggests that an increased prevalence of
parasite infection may prevent the development of asthma
in sensitized atopic individuals [243].
In contrast, children from Kenya living in rural areas
had a lower percentage of body fat, smaller and fewer
skin test responses to allergens, a higher prevalence of
IgE antibodies to Ascaris, and 10-fold higher total IgE
compared to urban children in Kenya. In the urban area
of Kenya, there was a strong correlation between exerciseinduced bronchospasm (EIB) and atopy determined both
by IgE antibodies and positive skin prick tests. By contrast,
in the rural area, none of the 13 children with EIB were
skin-test positive (vs 13/109 of children without EIB) [244].
Besides the above information regarding the upward
trend in the prevalence of asthma and allergies in Africa
as reported in the ISAAC study, another study has confirmed not only the increased prevalence of asthma but
also increased allergen sensitization. Two surveys conducted using the same methodology 10 years apart (1993
and 2003) among schoolchildren aged 9–16 years attending urban rich (UR), urban poor (UP), and rural (R)
schools were performed in Ghana. The prevalence of both
exercise-induced asthma (EIA) and sensitization approximately doubled over the ten-year period among Ghanaian
children and adolescents irrespective of location, with
both asthma and atopy being more common among the
UR than the UP and R children [245]. Moreover, students
from affluent schools had higher levels of IgE to mites
compared to those non-affluent and suburban/rural students from Ghana [246].
In a survey conducted in Kigali (the capital of Rwanda)
and in Huye District (a rural area located in southern
Rwanda), airflow obstruction was found in 256 participants (14 %). Of that number, 163 (8.9 %) subjects were
asthmatics and 82 (4.5 %) had chronic obstructive pulmonary disease (COPD). 584 subjects (26.5 %) had
positive skin-prick tests, and house dust mite and grass
pollen mix were the main allergen sources found. The
major risk factors for asthma were allergy, female gender, and living in Kigali [247].
All of this information confirms that asthma and allergic sensitization are becoming more prevalent in many
African countries and that this upward trend is mainly
related to sensitization to house dust mite, tobacco
smoking, and living in urban affluent westernized locations. The high prevalence of severe asthma found
in Africa in the ISAAC study (Fig. 4) suggests that
limitations in getting access to care, as well as the
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Fig. 4 Blue triangles identify locations where prevalence was reduced by at least 1 standard error (SE) per year. Green squares identify locations
where there was little change in prevalence (i.e., change of less than 1 SE per year). Red triangles identify locations where prevalence increased
by at least 1 SE per year. Reused with permission from Elsevier [141]

availability and affordability of medications, can contribute to severe forms associated with non-treated
patients, as defined by the World Health Organization
(WHO). A better socio-economic situation could help

to treat those non-treated patients and decrease the
severity of asthma and allergy [248, 249].
The tropical environmental factors which may cause
allergy include food items, animals, birds as well as the
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Fig. 5 Inhalant allergen sensitization pattern in children and adolescents in Zimbabwe. The vertical scale represents a percentage of some 987
sensitized patients. Source: Elopy N Sibanda

house dust mites and stinging insects (bees and wasps)
that are present, to varying degrees in all continents.
Plant derived allergen sources span trees, grasses, and
weeds which can be unique to local environments. There
is also sensitization to airborne mold spores. Tropical
dietary habits are influenced by the availability of edible
grains, plants, fruits and even insects. These are potential
sources of allergen sensitization and due to their habitat
specificity are likely to display regional peculiarities. This
discussion of allergen sensitization in tropical Africa is
limited to the observations that have been made in
Zimbabwe, a Subtropical African country. Examples from
some neighboring countries are incorporated [141].
The ISAAC was limited to a handful of centers in tropical Africa [141, 243]. In the limited number of centers,
the study reported prevalence rates of wheezing, allergic
rhino-conjunctivitis or eczema to range between 4 % and
27 % amongst 12–14 year olds in 22 centers selected from
16 African countries. These findings debunked the commonly held perception that allergies are infrequent in
Africa. Whereas the presence of wheezing, rhinitis,
conjunctivitis and dermatitis points towards allergen
sources as potential triggers, there remains a dearth of
studies that identify triggering specific allergen sources.
There have been limited attempts to correlate allergen
sources with clinical disease manifestations. In Zimbabwe
the predominant allergen sources are house dust mites
(D. pteronyssinus and D. farinae), grass pollen, animal
hair and molds [250–252] (Fig. 5).
House dust mites

House dust mite sensitization is ubiquitous, occurring
worldwide in both temperate and tropical environments.
House dust mites are the predominant sources of inhaled

allergens in Zimbabwe. Dust mite sensitivity is associated
with asthma and rhinitis. Approximately half (52 %) of all
the patients with asthma or allergic rhinitis and conjunctivitis are sensitized to house dust mites. While house dust
mite sensitization is ubiquitous, there are significant differences between specific house dust mite component
molecules that elicit allergic diseases in this tropical country compared to temperate climate, with Austria used as
an example. In Zimbabwe, the major allergenic molecules
are the Der p 1 (80 %), Der p2 (45 %), Der p 7 (35 %), Der
p10 (55 %). This allergenic molecule pattern differs from
the observations in Austria, where there was no (0 %)
sensitization to Der p 7. Similarly Group 10 tropomyosins
are comparatively high (55 %) in Zimbabwe compared to
the Austrian population (10 %). Higher prevalence of
Group 10 tropomyosin sensitivity has also been reported
from tropical Japan (80 %). Tropomyosins that are structurally similar to Der p10 are found in crustaceans (crab,
lobster, and shrimp) and insects (cockroaches). The
presence of crustaceans and insects is influenced by climate and geography. Significant differences in the IgEbinding frequency of Der p 11 (the mite paromyosin) have
also been observed between temperate (Austria 12 %,
France 5 %, Italy 7 % and Sweden 11 %) and tropical
(Zimbabwe) countries. In Zimbabwe, the IgE binding frequency of Der p 11 was much higher (36 %) and was associated with atopic dermatitis [253].
A careful analysis of specific allergenic molecules reveals
geographical variations in the prevalence of sensitization
and allergic reactivity to specific molecules (Table 5). Different house dust mite molecules can cause similar respiratory symptoms in different climatic environments.
There are implications on the diagnosis and management of allergic conditions. The use of house dust mite
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Table 5 Comparison of sensitization to house dust mite
molecules between a tropical and temperate country. Source:
Elopy N Sibanda
MW

Austria

Zimbabwe

rDer p1

26

96 %

80 %

rDer p2

10.7

15 %

45 %

rDer p7

23.7

0%

35 %

rDer p10

36

10 %

55 %

extracts in skin prick tests and/or in serological diagnostic techniques only provides a general guide to the
sensitization patterns. Component resolved molecular
detection techniques are required to identify specific
sensitivity patterns and regional specificities and ultimately to tailor specific immunotherapy interventions.
Cockroaches

Sensitization to cockroach allergens is common. Cockroach
allergy is a recognized cofactor in both asthma and rhinitis
and increases the severity of both. Asthma severity is
greater in cockroach sensitive subjects and is associated
with other atopic conditions such as dermatitis. Patterns of
sensitization to cockroach allergens were noted to be variable in two neighboring tropical countries (South Africa
and Zimbabwe). Patients who live in cities that are located
at higher altitudes (Harare, Zimbabwe and Pretoria, South
Africa) have predominant Blatella germanica sensitization,
whereas patients from coastal Cape Town and Durban
(both in South Africa) have a mix of B. germanica, Periplaneta americana and B. orientalis [254]. The results
show that sensitization patterns can vary within the
same climatic zones and are influenced by factors such
as proximity to the sea or altitude. However the relative
effect of sensitization to one or the other types of cockroaches in this region has not been investigated.
Pollen

The predominant grass pollen source is Bermuda grass
(Cynodon dactylon) which belongs to the Poaceae family
of grasses in Bermuda and Southern Africa. This is a
typically tropical grass whose optimum growth occurs at
temperatures between 24 and 37 °C and is most abundant
at latitudes between 30 °N and 31.4 ° + 7.5 °S. In view of
its value in soil erosion control, this grass variety was
widely planted alongside roads and school fields across
Zimbabwe and has become widely abundant. Bermuda
grass is implicated in seasonal exacerbations of allergic
rhinitis, asthma and allergic conjunctivitis.
Maize pollen (Zea mais) another Type 1 grass is a
common source of respiratory allergens in Zimbabwe.
Like Bermuda grass, maize belongs to the Poaceae family
of grasses and is an important cereal crops. It is widely
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cultivated in tropical climates and is responsible for respiratory and to a lesser extent food allergy.
Food allergy

Food allergen sources that are prevalent in Zimbabwe
reflect the dietary habits of the people. The full repertoire of these is limited by the availability of both skin
prick testing extracts and locally relevant test panels.
The reported results reflect a concordance of both skin
prick testing and serological assays of IgE mediated reactivity. The predominant food allergen sources are potato (24 %), peanut (21 %), rice (15 %), carrot (14 %),
soya (13 %), hazelnut (13 %) and wheat (11 %) (Fig. 6).
These allergen sources have been relatively recently introduced and became popular components of the diet of the
indigenous Zimbabwean population in the last 50 years. A
closer evaluation of peanut sensitization was conducted in
view of world reports of their association with anaphylaxis
and mortality.
A unique observation is that despite high levels of
sensitization to both potatoes and peanuts there are no
reported cases of severe peanut induced reactions or anaphylaxis. Peanut sensitization was demonstrated using
skin prick extracts and confirmed by allergen specific IgE
detected using the ImmunoCAP technique. Allergen specific IgE antibodies were also confirmed using a Western
blotting technique. All the extracts and serological reagents used were from commercial sources and were the
same that identified sensitization in patients with severe
reactions and anaphylaxis in temperate countries. Further
testing using resolved allergen molecular components
confirmed sensitization to rAra h 2, rAra h 1, rAra h 3,
nAra h 6 and rAra h 9. The levels of IgE antibodies to Ara
h 1 Ara h 2 were sometimes greater than 15 kUA/L. These
allergens and this level of sensitization is often associated
with severe reactions and anaphylaxis in temperate countries,
but not in Zimbabwe, suggesting unexplained peanut tolerance. Similar tolerance has been reported from Nigeria
[255]. The authors speculate that it is the method of peanut preparation and the timing of its introduction to the
diet that produces tolerance as opposed to allergy. There
may well be other explanations.
The Americas

The tropical area in the Americas extends from Mexico
in the Northern hemisphere to a line that crosses Paraguay
and the South of Brazil. Most of the Latin American
countries are part of the Tropics except Argentina, Chile,
and Uruguay. The Tropics also includes the southern half
of Mexico, Central America, and the Caribbean. The tropical South America sub-region comprising 10 countries
(Colombia, French Guiana, Suriname, Guyana, Venezuela,
Ecuador, Peru, Bolivia, Paraguay, and Brazil) represents
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Fig. 6 Allergen-specific IgE reactivity in patients presenting to the Asthma Allergy and Immune Dysfunction Clinic in Harare. Source: Elopy
N Sibanda

the greatest concentration of tropical rainforest in the
world. The Amazonian tropical rainforest is considered to
be the world’s richest ecosystem in terms of biodiversity.
The rainforest in South America is approximately 885 million hectares in the Amazon Basin and another 85 million
hectares in the Orinoco and Paraná watershed complex.
The total land area of tropical South America is 1,387 million hectares. The temperature in a rainforest rarely is
higher than 93 °F (34 °C) or drops below 68 °F (20 °C),
and the average humidity ranges between 77–88 %. The
rainfall is often more than 100 in. a year. Terrestrial biodiversity (degree of variation of life) tends to be the highest at low latitudes near the Equator. The tropics in
Mexico, Central and South America are extremely rich in
terms of genetic variation, species variation, or ecosystem
variation. For instance, Mexico is home to 10–12 % of the
world's biodiversity and is one of the 17 M diverse countries
as well as other 7 Latin American countries (Brazil, Bolivia,
Colombia, Costa Rica, Ecuador, Perú, and Venezuela).
The ISAAC Study in Latin America has shown that the
prevalence of lifetime asthma ranged from 1.2–33.1 %,
whereas current wheezing was from 3.9 to 30.8 %. An important proportion of centers (55 %) reported a prevalence
of asthma symptoms over 15 %. There was no significant
correlation between prevalence of asthma symptoms and
the latitude, altitude, or tropical setting. It is suggested
that ecological interactions, probably typical for each locality, may be the main determinants for the large variability of asthma prevalence in Latin America [256].
Regarding allergic rhinitis, 93,851 children (6–7 years old)
from 35 centers in 14 Latin American countries, and
165,917 adolescents (13–14 years old) from 56 centers
in 17 Latin American countries, were enrolled. The mean

prevalence rate of current rhinoconjunctivitis was 12.7 %
in the region while the highest prevalence was found in
Caracas (Venezuela) – 21.2 % of the schoolchildren. The
mean prevalence rate of current rhinoconjunctivitis was
18.5 % and ranged from 7.1 % in Cuernavaca (México) to
45.1 % in Asunción (Paraguay) for the adolescents. In
general the prevalence of rhinitis-related symptoms was
higher among the Spanish speaking centers. As it happens for asthma, a great variability in the prevalence
was also found for allergic rhinitis including differences
observed even in centers from the same country [257].
The prevalence of eczema in tropical Latin America is
also very high compared to other regions and countries
that participated in the global survey. The mean prevalence of current flexural eczema in schoolchildren was
11.3 %, ranging from 3.2 % in Ciudad Victoria (México) to
25.0 % in Barranquilla (Colombia). For adolescents, the
prevalence varied from 3.4 % in Santo André (Brazil) to
30.2 % in Barranquilla (mean prevalence, 10.6 %) [258].
Atopy is very common among children and adults with
asthma and/or allergic rhinitis. A study looking at the
prevalence of sensitization to 6 different mites species
(Dermatophagoides pteronyssinus, D. farinae, Blomia tropicalis, Chortoglyphus arcuatus, Lepidoglyphus destructor,
and Aleuroglyphus ovatus) in 297 children and adults with
asthma from 7 cities in 5 Latin American countries (most
of them tropical cities – Bogotá, Caracas, Cartagena, São
Paulo, and Mexico City) was performed. Sensitization to
D. pteronyssinus varied from 60.7 % in Cartagena to
91.2 % in São Paulo; to D. farinae from 53.3 % in Córdoba
to 97.2 % in Caracas; to A. ovatus from 26.6 % in Bogotá
to 71.2 % in São Paulo; to B. tropicalis from 46.5 % in
Mexico City to 93.7 % in São Paulo; to C. arcuatus from
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33.3 % in Mexico City to 75 % in São Paulo; and to L. destructor from 30 % in Mexico City to 76.2 % in São Paulo.
The studies carried out in São Paulo and Córdoba were
confined to children and thus could be compared; there
was a significantly higher prevalence of cutaneous sensitivity to mite allergens in the children of São Paulo (in the
Tropics) than in those of Córdoba (p < 0.001 for all mite
species). Cutaneous sensitivity to mite allergens is very
common in young and adult asthmatics in Latin America,
in areas both at sea level and at high altitudes [259].
More recently, it has been shown that 76 % of patients
with respiratory allergy are sensitized to aeroallergens,
especially mites in Caracas, a tropical city [260]. Moreover, anaphylactic reactions after the ingestion of mitecontaminated pankakes has been also described in
Venezuela indicating that not only the inhalation of
mite particles but also ingestion can elicit oral mite allergic reactions [261]. An online registry of anaphylaxis has been developed and 191 patients registered
from Latin America and Portugal. Anaphylactic reaction to foods (36.1 %), drugs (27.7 %), and insect stings
(26.2 %) were analyzed. The most common symptoms
during an acute episode were cutaneous (94.2 %) as
well as respiratory (78.5 %). Most patients were treated
in emergency setting, yet only 34.6 % received injective
epinephrine and 14.3 % had to be hospitalized. The
management of anaphylaxis needs to be improved in
the region [262].
Environmental features in the tropics in Latin America
have to be taken in account regarding risk factors and
potential pathogenic agents. Ascariasis infections are important health problems in low-income settings such as
those located in the tropics where environmental conditions also promote the perennial co-exposure to high concentrations of domestic mite allergens. Experimental
evidence of a high cross-reactivity between the allergenic
extracts of these invertebrates, involving well-known allergens such as tropomyosin and glutathione transferasas
has been described [263]. Ascaris lumbricoides induces a
Th2 response and specific IgE synthesis in humans; in
addition, Ascaris tropomyosin is cross-reactive to mite
tropomyosin and can induce wheal and flare reaction in
skin prick tests and histamine release from basophils.
There is indirect evidence suggesting that the clinical impact of these findings may be important [263].
In a recent study performed in the north of Brazil, it
was found that children of more educated mothers, living
in improved environmental conditions, and with a low
burden of infection were significantly more likely to
have the responsive phenotype. The so-called responsive
phenotype was significantly associated with an increased
prevalence of atopy but not asthma. A better understanding of the underlying immune mechanisms of the hygiene
hypothesis in urban Latin America is needed [264].
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Early life sensitization to aeroallergens, presence of
atopic dermatitis or allergic rhinitis, maternal smoking
during pregnancy and children's environmental exposure
to tobacco smoke, lower respiratory tract infections with
respiratory syncytial virus and potentially with other viruses including rhinovirus and metapneumovirus, exposure to air pollutants, several perinatal factors other than
maternal smoking, are among the factors associated with
an increased risk for the development of chronic diseases like asthma and atopy [265].
Conclusions

Allergen sources predispose to allergic diseases in genetically predisposed individuals worldwide. This is true
and expected for allergen sources that are geographically
demarcated such as food items, tree and grass pollen.
There are also significant differences with ubiquitous allergen sources such as house dust mites and cockroaches.
The molecules responsible for allergy vary geographically.
Tropomyosins contribute more to allergy in the tropics
(Japan, Zimbabwe) than they do in the temperate regions.
While the allergen sources may be the same, the allergen
molecules differ, necessitating component resolved diagnosis and targeted treatment for house dust mite allergy.
Cockroach allergy varies with altitude and proximity to
the sea. The germanica species thrive in high altitude
whereas the P. americana are in low altitude. The lesson
to be learned is that while major allergen sources may be
ubiquitous, local variations impact on accurate diagnosis,
prevention and treatment of resultant allergic diseases.

New emerging factors with migration
The prevalence and impact of allergy have been associated with environmental and lifestyle changes accompanying the continuous process of urbanization and
globalization. Changing environmental factors are most
likely important in explaining the trend of asthma prevalence worldwide. Asthma is the result of environmental
factors on a genetically susceptible subject. Socio-economic
background, family size, urban dwelling, farm exposure, infections, diet, obesity, drugs, tobacco smoke exposure and
indoor and outdoor air pollution are among the factors associated with atopic disease [266].
Comparative studies have demonstrated that asthma
and related allergic disorders are more common in westernized or urbanized societies than in rural or developing countries [267]. Asthma prevalence appears to have
peaked or reached a plateau in countries with a high
prevalence but is still rising in some. Urbanization and
economic development cannot explain the reason for a
lower prevalence of asthma in cities such as Singapore,
Seoul, and Hong Kong as compared to the United Kingdom
and Australia [268].
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Rural environment, farming exposure to a microbial
diversity and animals, and consumption of unpasteurized
farm milk have protective roles for asthma and allergic
disorders [269–271]. Exposure to poultry and livestock in
a farm environment could reduce the prevalence of hayfever and atopic sensitization in children born and raised in
farms [272, 273]. A study of the differential effects of farmassociated exposures on specific asthma-related health outcomes demonstrated that the asthma-protective effect of
being raised on a farm could be attributed to pig farming,
feeding silage, child’s involvement in haying, farm milk consumption, and regular stay in animal sheds and barns. The
microbial compounds (extracellular polysaccharide, endotoxin and glucans) measured in mattress dust did not
explain the inverse relation of asthma prevalence [274].
The disparities in asthma prevalence and morbidity
among the world's geographic locations are more likely
to be associated with environmental exposures than genetic differences. In Malaysia asthma and asthma-related
symptoms occurred more frequently in urban than in
rural areas, and that difference correlated with environmental risk factors such exposure to dust mites, high
levels of vehicle emissions, and a westernized lifestyle. In
urban areas, biomass fuels have been widely replaced by
cleaner energy sources at home, but in developing countries, coal is still a main fuel for heating in winter and
cooking. Among the poor, cooking devices that are
placed in inadequately ventilated spaces have direct
health impact [275, 276]. A study investigating the annual
respiratory symptoms of 3,049 Japanese students from 8
urban and rural areas showed a positive association between regional NO2 levels and asthma prevalence [277].
Moving from traditional/rural to modern/urban societies
could explain the increase in asthma prevalence in developing countries. Rural areas tend to have a low asthma
prevalence protected by factors associated with a traditional rural lifestyle [278–280].
Potential risk factors for asthma related to urbanization
have been identified: reduction in the frequency of infections;
reduction in family size; increasing vaccine coverage; use of
antibiotics; increases in environmental pollution and household exposure to allergens; changes in diet, lifestyle and socioeconomic aspects [281]. Acquiring allergy is influenced
by the age at the time of immigration. Migrants, in general,
are more prone to the development of allergies than the
local population [282].
The prevalence of both EIB has approximately doubled
over the 10-year period amongst 9- to 16-year-old
Ghanaian children irrespective of location, with EIB being
more common among the urban than rural children [245]
(Table 6). The overall reported prevalence of the CNCDs
(diabetes mellitus, hypertension, cardiovascular disease,
asthma, epilepsy, depression and mental illness) was
found to be 8.9 % in Ethiopia. The specific observed
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Table 6 Prevalence of asthma in urban and rural areas of
developing countries [245, 283–291, 295]
Country

Author, year

Urban

South Africa

Steinman 2003

33

17

Zimbabwe

Keeley 1991

5.8

0.1

Ethiopia

Yemaneberhan 1997

3.6

1.6

Ghana

Addo Yobo 1997

4.7

2.2

a

Rural

Ghana

Addo-Yobo 2007

8.3

3.9

Kenyaa

Ng’ang’a 1998

22.9

13.2

Kenya

Odhiambo 1998

9.5

3.0

Saudi Arabia

Hijazi 1998

14.9

5.4

South Africa

VanNiekerk 1979

3.17

0.14

Peru

Robinson 2011

12

3

Brazil

Solé 2007

16.7

15.3

a

a

Exercise-induced bronchospasm

prevalence of asthma was 1.5 % similarly to the rate
found 15 years ago in rural Ethiopia [292].
Atopic sensitization to indoor allergens such as house
dust-mite and cockroach is strongly associated with asthma
symptoms among urban compared to rural Ghanaian children [293]. A diversity of factors may influence the lower
prevalence in rural areas [293]. Although the exact protective environmental factors in the rural region remain to be
defined, there have been many studies suggesting that early
exposure to microbes or microbial products may play a role
in modulating the immune system so as to reduce the
future risk of asthma and allergies [294]. Asia-Pacific
is one of the most densely populated regions of the
world and is experiencing rapid economic changes and
urbanization. Although the prevalence of asthma and
allergies remains relatively low in Asia compared with
other regions, the rapid modernization of many cities
in South Asia has an increased the prevalence and severity
of asthma [268].
Urbanization is a complex array of changes that modify
the living environment and human behaviors, which can
be significantly associated with current asthma symptoms.
Higher asthma prevalence has been found in Ecuadorian
communities with a higher socioeconomic level and a
more urbanized lifestyle [281]. Robinson et al., studied
13–15-year-old adolescents living in two coastal regions
of Peru: Pampas de San Juan de Miraflores, a peri-urban
shanty town in Lima with high population density centered on a heavy traffic route, and 23 rural villages with
little traffic outside Tumbes city in northern Peru. Significantly higher current asthma symptoms (12 % vs 3 %),
current rhinitis (23 % vs 12 %), eczema (12 % vs 0.4 %),
atopy (56 % vs 38 %) and higher exhaled nitric oxide
(eNO) values were observed in urban adolescents [290].
The prevalence rates for asthma in Kenya, defined as
“attacks of shortness of breath with wheeze”, were
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9.5 % for urban and 3.0 % for rural children (odds ratio
(OR) urban versus rural: 3.42; 95 % confidence interval
(CI): −1.96–5.91) [290]. The prevalence rates of exerciseinduced bronchospasm (EIB) were considerably higher in
urban than in rural African children [286]. Methodological
differences (age groups, definition of current asthma,
questionnaires) likely explain the differences observed
in epidemiological studies. Urban–rural differences in
diet, the frequency and nature of childhood infections,
exposure to industrial and motor vehicle emissions have
been implicated. In addition aeroallergens distribution
may vary accordingly with the environment [286–289].
Higher rates of current symptoms of asthma and rhinitis
but not eczema had been reported for adolescents living
in two urban centers of ISAAC study in Brazil as compared to those living in rural areas [295].
Conclusions

Migration involves exposure to a new set of pollutants and
allergens as well as changes in lifestyle conditions, all of
which are likely to affect migrants' health [159]. Undoubtedly, migration from rural regions to urbanized centers is accompanied by an increase in prevalence rates of asthma in
different regions of the world. The reasons of this trend are
diverse and there is interaction between environment risk
factors and a genetically susceptible host. Research efforts
must achieve sustainable results on prevention, diagnosis
and treatment of this most prevalent chronic disease both
for populations in developing countries and for immigrants
from such countries to atopy prevalent ones [159, 266].

The role of air filtration as an environmental
control measure for allergic disease
In the treatment of asthma and allergies, the most effective environmental remediation strategies are multifaceted
interventions [296–299]. Control of the environment requires attention to exposures that originate from both the
outdoor and indoor environments. Avoidance of environmental factors that provoke asthma, where feasible, is a
logical way to improve asthma-related health and to
minimize the need for long-term use of asthma medications. Air filtration is frequently recommended as a component of environmental control measures for patients
with allergic respiratory disease [297–300].
The association between preventive asthma care and
comprehensive environmental control practices was examined in a review of 3,727 adults with asthma by Roy
and Wisnivesky [301], using data from the Four-State
National Asthma Survey. Comprehensive management
was defined as the implementation of combinations of at
least five of eight measures. Air filtration was found to
be the fourth (27.4 %) most commonly implemented
strategy, preceded only by no smoking (80 %), no pets
(53.9 %), and washing sheets in hot water (43.2 %), and
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followed by pillow covers (23.7 %), mattress covers
(23.4 %), no carpets (14.5 %), and use of a dehumidifier
(13.8 %) [301]. A similar study in the pediatric population found the same rate of air filtration (27.4 %) use in
the households of asthmatic children [302].
Residential air filtration can be provided by whole house
filtration (WHF) via the home’s heating, ventilation, or air
conditioning system (HVAC) by portable room air cleaners
(PRACs), or a combination of the two [302]. Use of highefficiency particulate air (HEPA) filters reduce airborne allergens in the indoor environment and may provide clinical
benefits for patients with respiratory allergies [130].
The role of air filtration in disease prevention has been
studied for long time but it continues to be debated.
Several investigations have demonstrated that indoor air
cleaning devices can reduce concentrations of asthma
triggers in indoor air [297, 303–317]. Recently, Brown
et al. [297] evaluated the performance of different grades
of filters in a modeling, identifying filters to be effective
at reducing airborne asthma triggers by at least 50 %.
In a study conducted by Du et al. [303], using HEPA
filters reduced particulate matter by 69–80 % in the
homes of children with asthma. Previously it was demonstrated that substantive reductions in fine particulates
were attained in ambient space with the use of enhanced
efficiency WHF [304].
Macintosh et al., [305] also found WHF to be effective
in removing fine particles from indoor air. Lanphear
et al., [306] conducted a double-blind randomized control trial of 215 asthmatic children with known secondhand tobacco smoke exposure. The intervention group
received 2 HEPA filters and the control group received 2
sham air filters. It was demonstrated a reduction of airborne nicotine particles and in the number of unscheduled asthma visits in a 12-month follow up period in the
intervention group. There was not a difference in serum
or hair cotinine between the two groups [306].
Recent investigations suggest that HEPA air filtration
reduces mold levels in hospital clinical units [307] and
reduces fine PM (diameter, <2.5 μm) exposure during
forest fires and residential wood burning [308]. Lingell
et al. [309] conducted an environmental remediation in
a school in Finland with poor air quality and high levels
of mold. After installing a ventilation and exhaust system,
there were lower levels of mold but this was not associated with fewer respiratory complaints.
In a study by Wood et al., excluding cats from the bedroom and using HEPA filters were found to be effective in
reducing cat allergen levels; however, there was no reported improvement in asthma or allergic rhinitis
symptoms [310]. Van der Heide et al., [311] conducted
a 3-month HEPA filter intervention study in 20 petsensitized children with asthma and demonstrated significant reductions in bronchial hyperresponsiveness
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but no differences in symptom scores or medication
use in pet-sensitive asthmatic children. These results
were not replicated in a similar study [312]. Reisman
found reductions in asthma/rhinitis symptoms during
active HEPA filter use [313].
Morgan et al., [314] as part of the Inner-City Asthma
Study Group, conducted a randomized controlled trial
of comprehensive ECPs in 937 children with atopic
asthma. Interventions included the use of a HEPA room
air cleaner in the child’s bedroom if the child was exposed
to ETS, sensitized and exposed to cat or dog allergens, or
sensitized to mold. The intervention group reported significantly fewer symptoms of asthma during the intervention year and the follow up year [314].
A review of 10 randomized controlled trials by McDonald
et al., [315] reported that HEPA air filtration was associated
with symptom reduction. However, caution was suggested
by methodological flaws in most of the studies. Morris
et al., [316] found significant reductions in allergic rhinitis
symptoms in ragweed-sensitive children and adults. Brehler
et al., [317] reported improvement in seasonal allergic rhinitis symptoms with air filtration through a wall-mounted filter. Sublett et al., [130], in his air filtration review,
concluded that there is sufficient evidence to suggest that
air filtration decreases allergic respiratory disease progression. Studies support multiple interventions, including air
filtration, as methods to improve outcomes in the treatment of allergic respiratory diseases. In addition, considering the enormous burden of asthma in terms of costs and
adverse health effects, air filtration is a relatively low-cost
component of efforts to reduce allergens in homes.

Cold weather
Positioning of “cold” within the context of global warming

Cold air has well defined effects on the lungs both in
terms of the individual asthmatic patients and of the respiratory health of susceptible populations. However,
when discussing climate changes allegedly due to anthropogenic activities, the emphasis is placed on global
warming usually in conjunction with air pollution. The
general perception is that the overall rise in mean
temperature of 2 °C above preindustrial levels associated
with unprecedented high CO2 of 396 · 8 parts per million in early 2013 is creating periods of draught, wildfires
and enhanced harmful effects of air pollution affecting
more severely the poor and underprivileged layers of
human society [318]. Not surprisingly effects of cold
climate remain out of the focus of the media unless
spells of unusually cold weather sweep through a local
area. However, noteworthy features of climatic change
are unstable weather conditions associated among other
things with extremely cold periods of increasing frequency
and duration. An ongoing project in the European Union
with the acronym PHASE (Public Health Adaptation
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Strategies to Extreme weather events) is specifically meant
to look at the interaction between air pollution and extreme weather events (e.g. heat waves and cold spells)
[319]. Cold weather episodes in turn introduce an element
of uncertainty in society as to the reality of climatic warming as a global phenomenon. The skepticism that global
warming is real increases during cold weather spells as evidenced by analysis of US media coverage and opinion
polls since 1990; conversely, concerns that global warming
is imminent and menacing surge when average temperatures are soaring [320].
Cold air alone or in combination with other factors

Temperatures fluctuate around the year depending on
the latitude of a given region, its altitude, and the proximity to large water reservoirs. It is common knowledge
that the winter season in the higher latitudes is the worst
part of the year for many patients with chronic respiratory diseases. To obtain information on the extent and
severity of asthmatic symptoms during daily life in winter,
a simple questionnaire was sent to 57 asthmatic patients
and a control group of 180 age-matched men and women
in Göteborg (Sweden). The average winter temperature
there is at about the freezing point. About two-thirds of
the asthmatic patients reported cold to be a factor causing
breathing difficulties. In 37 %, these symptoms made the
patients avoid going out during the winter [321].
However, there is no “universal” numerical value of air
temperature that can be accepted as cut-off point for “cold”.
It is rather the magnitude of downward temperature
change below the mean seasonal range for a given area that
challenges the adaptive ability of people. Mortality increased to a greater extent with given fall of temperature in
regions with warm winters, in populations with cooler
homes, and among people who wore fewer clothes and
were less active outdoors [322]. As adaptive capacity
shrinks with age, it is the elderly who are mostly affected.
Thus, it has been documented that cold temperatures are
associated with a 3–4 % increase in daily mortality and
hospitalization for respiratory causes in the population over
75 years old for each degree Celsius decrease in minimum
temperature or minimum apparent temperature (defined as
a combined indicator of temperature and humidity above a
city specific threshold level ranging from 23-29 degrees
Celsius) [323, 324].
The effect of cold temperature is modulated by other
ambient conditions too. As an example, cold damp air
was reported by asthmatic patients to cause more symptoms than cold dry air, while the control group reported
very few respiratory symptoms [325]. Modeling of the effect of cold air is rendered much more complex when
combinations of several meteorological variables are
considered. Such combinations are referred to as
“synoptic air masses”, where humidity, visibility, cloud
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cover, air pressure, wind speed and others are added
into the equation and are known to influence mortality
and morbidity [187]. It is conceivable, though, that in
such sophisticated models specific evidence for respiratory causality is difficult to obtain.
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airways [335]. Furthermore, cold-related impairment of
respiratory mucociliary function can inhibit the clearance
of pollutants [336]. Finally, in extreme cold temperatures,
people tend to gather indoors and crowding can promote
the transmission of infectious agents with ensuing airway
inflammatory events.

“Cold” and air pollution

Climate change and air pollution due to anthropogenic
activities are intrinsically connected since greenhouse
gases and air pollutants originate from the same source fossil fuel combustion. The bulk of air pollutants are associated with increase of temperature, discussed elsewhere
in this monograph. Alternatively, nitrate particles, as well
as organic carbon aerosols have a cooling effect on the climate. Sulfur dioxide partly converts to sulfate particles,
which also have cooling potential, so they partly react with
black carbon, neutralizing its strong warming effect [324].
Also in some cases as in the study of Carder et al., cold
temperatures in conjunction with black smoke concentrations increases respiratory mortality [326]. Since extremes
of cold and particulate pollution may coexist, for example
during temperature inversion, these results may have important public health implications.
Mechanisms of cold air effects

The respiratory system may be particularly affected by
cold air exposure as inspired air has to be conditioned
before participating in peripheral lung gas exchange,
with an associated loss of heat and water. Furthermore,
when the individual exercises, nasal breathing quickly
switched to mouth breathing, particularly at minute ventilations above 40 l per minute, with the involvement of
intrathoracic airways in this conditioning process [327].
Although exercising in cold air has minimal influence
on airways of normal individuals, it can induce a bronchoconstriction in asthmatic subjects and worsen airway obstruction in those with obstructive pulmonary diseases
[328]. Winter athletes can be particularly affected by these
environmental conditions, and an increased prevalence of
airway hyperresponsiveness, asthma and chronic cough has
been described in this population [329–331]. Bronchial biopsies of winter athletes have shown evidences of airway remodelling, possibly due to the repeated cold-air and
hyperventilation damage to the airways, although more research is needed on this influence on airway function [332].
The mechanism of bronchoconstriction as a response to
exercise-induced hyperpnoea, particularly in cold air, has
been studied and seems mostly related to an increase in airway fluid osmolarity following hyperpnoea, although heat
loss may be a modulator of this response, as well as a possible post-exercise “rewarming” of the airways [333, 334].
Even in normal subjects, cold air can induce changes
in the airways. Exposure to cold air can increase the
number of granulocytes and macrophages in the lower

Role of the upper airways in health and asthma

Breathing cold air has been long recognized to trigger
bronchoconstriction in asthmatics. In a classical experiment
Shturman-Ellstein et al., demonstrated that if subjects with
asthma breathed only through the nose during the exercise
challenge, an almost complete inhibition of the post
exercise bronchoconstrictive airway response was observed
[337]. However, as the nose is serving as outermost filter
for the inspired air, it is exposed to environmental hazards
with consequent high incidence of morbidity. Adding to
this genetic atopic predisposition, it is likely that asthmatic
subjects have concomitant rhinitis, which does not allow
proper conditioning of the inspired air with negative impact
on the asthmatic condition. The cross-talk and interplay
between upper and lower airways has been a center point
in the philosophy of the Allergic Rhinitis and its Impact on
Asthma (ARIA) initiative and has been reconfirmed over
the years [338].
The upper airways mucosal structures are particularly
sensitive to cold air influences. Challenges with cold dry air
have been proposed to assess the state of nasal responsiveness in both allergic and non-allergic rhinitis [161, 339,
340]. This line of research is substantiating the importance
of cold weather as trigger in the pathogenesis of rhinitis,
which in turn is a recognized risk factor for the development of asthma [341]. Cold weather spells as a characteristic feature of changing climate will need to be considered in
assessing the risk for asthma, especially since heterogeneous
human populations may adapt differently to them [342].
Conclusions

There is a need to better define the consequences of repeated exposure to cold air and the mechanisms by
which such exposure could modify airway function and
affect the outcomes of patients with pre-existing airway
disease. This could help promote adequate policy and
public health actions to face the incoming challenges. By
all means distinction should be drawn between effects to
individuals and effects to populations, as populations are
heterogeneous in their susceptibility, reversible and irreversible effects should be identified [343].

Wildfires and asthma
Wildfires include bush fires, vegetation fires, forest fires,
and heath and grass fires. These events are widely prevalent around the world and there is evidence that their
incidence is increasing. Their cause may be accidental or
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deliberate, to create deforestation. Increasingly reports
consider that the occurrence of wildfires are strongly determined by the incidence of drought and heat waves
with climatologists believing that climate change will increase their incidence as the associated droughts and
heat waves are expected to increase in frequency and intensity [344].
Over the past 5 years, serious wildfires in Chile [345],
Australia [346] and California [347] have reminded the
global community of the devastating effects uncontrolled
fire may cause. In Europe, there are on average 70,000
forest fires annually. These are an almost annual feature
in countries with warmer climates such as Portugal,
Greece and France, particularly in the island of Corsica.
Apart from obvious burn and other physical trauma
caused by wildfires there are also other, less obvious
health effects. These have been far less documented than
the health effects of heat waves and heat exposure.
Recently, a number of published studies have examined
the health effects of wildfires. A study in the United
Kingdom (Finlay et al., 2012) [348] set out to collate and
review the evidence regarding human health impacts from
global wildfire experience. This study identified a wide
range of health effects but the respiratory effects were
shown to be the most important, both in the short and
long term. A further study examining the estimated global
mortality attributable to smoke inhalation from wildfires
was published by Johnson et al., in 2012 [349]. These and
other studies have emphasized the importance of respiratory health problems associated with wildfires.
Aspects of the epidemiology and pathophysiology of the
respiratory effects of wildfire smoke

The particulate matter (PM) in smoke is defined in
terms of particle size: 10 μm particles are distributed in
the small bronchi while 2.5 μm particles can penetrate
the terminal bronchioles and the alveoli. The 10 μm particles (PM10) have been widely studied in urban air pollution but PM10 from wildfires appear to have different
effects on health than urban PM10. An 8-year study
[350] investigating air pollution levels, including those
from bushfires, and hospital admissions showed that a
10 μg/m3 increase in bushfire (but not urban) PM10 was
associated with a 1.24 % increase in all respiratory admissions, a 3.80 % increase in COPD admission and a
5.02 % increase in adult asthma admissions. Increased
levels of urban PM10 were associated with an increase in
all-cause and cardiovascular mortality but not respiratory mortality alone.
Studies from Darwin, Australia, are particularly useful
as there is very little background urban PM10 pollution
and therefore most rises in air pollution in that area are
secondary to bushfires [351]. Studies from this area
[352, 353] report a significant increase in asthma and
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COPD presentations associated with raised PM10 levels
from bushfire smoke.
The difference between urban and wildfire smoke is
also illustrated in a study looking at the effect on macrophages exposed to wildfire and urban smoke in a murine
model [354]. This showed that although cytokine production in response to wildfire smoke was lower than with
urban derived particles, there was increased inflammatory
(determined by measuring proinflammatory cytokines)
and cytotoxic activity (as measured by biochemical
markers of toxicity, apoptotic activity and nitrous oxide
production) per cubic meter of air containing wildfire particles than with air containing only urban particulate matter.
This was probably as a result of a higher concentration of
PM10 particles in the wildfire smoke (10.3 μg/m3 compared
with 5.5 μg/m3 in urban air). This increased concentration
may have public health implications.
Wood smoke particles have also been shown to cause
an inflammatory response in otherwise healthy humans.
The Ghio et al., [355] study of 10 human volunteers exposed to woodfire smoke showed an increased level of
blood neutrophils, and a neutrophilic influx into the lung
evidenced in bronchial and bronchoalveolar lavage samples. Although this was a small study, the authors suggest
that systemic and pulmonary inflammation in human subjects can result from exposure to wood smoke particles.
A crude extrapolated estimate from Finland suggested
that high PM2.5 levels following wildfires in 2002 caused
additional total mortality of 9–34 cases in a population
of 3.4 million compared with what would normally be
expected [356]. High levels of PM10 (both urban and
from bushfires) were associated with a 1.8 % increase in
ED attendances in a study in Victoria (carried out during
a bushfire season in 2003–2003) [357]. A system of
monitoring air pollution during and after wildfire events
may provide useful public health information, facilitating
preparedness for increased pressure on health care services, and should be considered after wildfire events. It
would be important to monitor PM2.5 levels, not just
PM10 levels. PM10 monitoring alone may not adequately
represent the adverse effects of air quality that may be
caused by the PM2.5 fraction [358].
Exacerbations of respiratory conditions following
exposure to wildfire smoke

A number of published studies have examined symptoms of chronic obstructive airway disease (COPD) and
asthma following exposure to the products of combustion of wildfires. These may be summarized as follows.
Patients with COPD have been noted to be at increased
risk as a result of wildfire – generated air pollution. A
study [358] looking at symptoms of 21 local patients with
COPD in the 2 months following the Denver wildfires
of 2002 revealed that dyspnoea, cough, chest tightness,
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wheeze and sputum production all increased on days
when PM2.5, PM10 and carbon monoxide levels in the
atmosphere increased. This study provided a clear illustration of the link between air pollution from wildfires
and COPD exacerbation. Wheeze was amongst the observed increased respiratory symptoms.
In a pediatric cohort study, 32 children with a history of
wheeze suffered adverse effects from increased PM10 particles after the 2009 Australian bushfires. This study found
that, although symptoms of evening wet cough worsened,
dry cough and wheeze did not [359]. A study of 465 nonasthmatic teenagers affected by 2003 wildfires in Spain revealed that healthy patients who performed on the lowest
quartile of lung function tests were more susceptible to
the respiratory effects of wildfire smoke [360].
Data from the 1994 Sydney bushfires show that there
was no increase in acute asthma related admissions in
central Sydney [361] or Western Sydney [362] in the
aftermath of the fires. This may not however reflect the true
prevalence of asthma exacerbations, as only the more
severe cases would be expected to present to the ED. In the
days following the 1987 Californian bushfire, there was a
40 % increase in ED attendances [363].
It should be noted however that hospital attendance
records may not be a reliable indicator of exacerbation
of asthma attacks following exposure to wildfire smoke.
This was revealed by a cohort study from Darwin
(Australia) which showed that attendance studies may
underestimate the respiratory symptoms [364]. In this
study, 251 adults and children were asked to keep a record of their asthma symptoms during a 7 month bushfire period in 2004. During this time, PM10 ranged from
2.6–43.3 μg m−3. High PM10 levels were significantly associated with an onset of asthma symptoms, use of oral
steroid medication, the mean daily symptom count and
the mean daily dose of beta 2 agonists. Despite these indicators of an increase in asthmatic symptoms there was
no recorded increase in the numbers of health care attendances or severe asthma attacks.
An increase in respiratory symptoms and deteriorating
lung function was also seen in a study of findings reported
by respiratory physicians and governmental reports in
Indonesia at the time of the Indonesian wildfires of 1997
[365]. Worsening of respiratory symptoms were seen during the same period in surrounding countries such as
Malaysia [366] and Singapore [367], illustrating the ability
of particulate matter and air pollution to spread widely.
94 % of the air particles noted in Singapore in the haze following the Indonesian fires were PM2.5, and emergency
department attendances related to the haze increased
although overall hospital admissions due to respiratory
effects did not [367]. These effects were observed more
than 500 km from the bushfires. Delayed health effects
may also occur. One study looking at health effects after
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the 2003 Canadian wildfires showed that there was a peak
in respiratory consultations 5 weeks after the fires. This
may be because of delayed respiratory health effects of
wildfires smoke [166].
Following a peatbog wildfire in rural area of 42 North
Carolina counties, an increase of cumulative risk of asthma,
COPD, and pneumonia and acute bronchitis among the
population of counties exposed compared to non-exposed
counties was observed. ED visits of all respiratory diagnosis
and cardiopulmonary symptoms were increased in the exposed counties [368].
Uncertainty in the assessment of exposure to wildfire-related
air pollutants

To evaluate the health impact of wildfire exposure, studies
have used several exposure assessment methods [369] including self-reported questionnaires [370], routine data
(number of wildfires) [371], air quality monitoring stations
[357], and satellite data with visibility or aerosol optical
depth (AOD) [368], etc. The purpose of these methods is
to better estimate the personal exposure to wildfire emissions in order to better evaluate their health impact. Different degrees of uncertainty are associated with these
methods [369].
Exposure assessments based on a self-administrated
questionnaire which estimates the exposure to fire based
on the declaration of the individuals threatened by flames
are poor and underestimate real exposure. In addition, fire
emissions may not be quantified but based on fire smell
[370], which is not sufficient to determine an exact exposure. Several studies have also used air quality monitors to
estimate the concentration of air pollutants emitted by a
fire, especially PM. Limitations of monitoring stations include not being able to monitor an entire wildfire area and
being damaged by the fire [372]. The veritable problem,
however, is to distinguish wildfire emissions from those
caused by other sources. This problem arises frequently
for all quantitative methods.
More recently, satellite data are used to evaluate wildfire
exposure because spatially-resolved particle mass data
provided by satellites is superior to using data provided
only by the nearest available monitoring station data
[372]. However, it is important to recognize that errors in
satellite resolution at the ground level may occur and satellite data cannot be retrieved (or has more uncertainty) if
a region is cloudy or has strong reflection of the sun from
bodies of water and over snow (ice and bright desert
areas). In some regions, correspondence between satellite
data (AOD) and PM2.5 has not been found, as may occur
when aerosols are entirely aloft above the boundary layer
and, therefore, do not influences surface air quality [373].
Notably, all of the described approaches may be combined within a modeling system, which is currently the
only tool to allow separation of wildfires and other
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pollution sources impacts through different simulations.
In addition, giving spatial coordinates with satellite data
allows the estimating of wildfire exposure at zip code level,
which may be not representative of individual exposure.
What can be done to mitigate the potential asthmatic
sequelae of exposure to wildfire smoke?

When there is a threat of wildfires due to extreme climatic conditions or an outbreak has occurred unexpectedly there are a number of measures that can be taken
by health authorities to reduce the impact of the fire
upon asthmatics [374, 375].
These include:
1. Limit exposure wherever possible.
Considering the potential toxicity of wood fire smoke,
it is advisable to minimize exposure:
 Air quality reports should be checked. These may

have the potential to be used in conjunction with
surveillance of symptoms to understand health
effects and their link with air pollution.
 Indoor air should be kept as unpolluted as possible
by keeping windows and doors closed and shutting
off external ventilation.
Identification of persons at risk and removal from the
exposure hazard if possible or encourage sheltering. In
cases of severe particulate hazards, filtration masks may
be of value. Evidence for the effectiveness of masks,
however, is limited. The avoidance of outdoor activities
for those vulnerable to respiratory pathology should be
recommended [374].
Access to homes, health care facilities and resources
may be impeded.
 Systems should be in place to ensure delivery of

medication and provisions to those who need them,
especially vulnerable groups.
 People living in areas prone to wildfires may be
advised to keep a stock of 5 days’ worth of
non-perishable provisions and medications.
 Measures to maximize safety of routes to and from
vulnerable areas should be in place
 Housing and evacuation routes in rural areas should
be clearly signposted
2. Emergency services and GPs should be prepared for
increasing numbers of patients attending with respiratory symptoms.
 Those with chronic respiratory illness may

experience a worsening in their respiratory
symptoms.
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 There may be an increased incidence of mild

respiratory symptoms amongst previously healthy
individuals, which may require some medical
treatment.
 Increased doses of anti-inflammatory and bronchodilator
medication may be required. Stocks of drugs should be
sufficient to accommodate for this.
 Provision of extra respiratory support in emergency
facilities for patients with smoke induced respiratory
distress should be considered. Measures that should
be considered include non – invasive respiratory
support such as continuous positive airway pressure
support (CPAP) and the provision of a supply of
portable emergency ventilators for severe cases of
respiratory distress and failure. For patients with
exacerbations of asthmatic symptoms at home the
provision of electrically-powered oxygen concentrators
which can provide a low pressure flow of oxygen up to
around 5 l/min will be useful for emergency domicile
management of respiratory distress leading to hypoxia.
Conclusions

Inhalation of the products of combustion from wildfires
has been shown to lead to exacerbation of a number of
respiratory conditions and asthma in particular. A number of simple measures can help to mitigate these effects
including simple public health advice on avoiding exposure and to encourage sheltering.
With the current global increase in wildfires and of destruction of forests by deliberate burning, all health care
workers, particularly general practitioners, respiratory
and emergency physicians need to understand more
about the associated health risks and the requirements
for early recognition of effects and treatment. More research is needed to evaluate long-term health effects
from exposure to wildfires, and careful identification and
follow up of those exposed could help in this process.
Health care workers treating casualties from wildfires
should be encouraged to publish case studies of health
effects to increase the evidence base available to the
international medical community dealing with wildfires.
Long term, longitudinal studies looking at health effects
in populations exposed to wildfires are needed.

Violent conflict and asthma
This section explores the linkages between violent conflict (hereafter “conflict”) and asthma and looks at
whether conflict (e.g., causes and consequences) has any
potential impact on asthma prevalence and treatment.
The section starts by outlining some of the common
characteristics and trends of conflict and of the countries
most affected by it. It then looks at the possible linkages
between conflict and asthma in general terms. Lastly, it
explores the linkages between conflict, access to health
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services, and asthma treatment. The section concludes
that insufficient data on asthma prevalence in countries
affected by conflict and of the linkages between conflict
and asthma does not allow establishing any direct and
solid correlation. More research is needed to understand
the specific interaction between conflict and asthma.
Violent conflict: an overview of trends

Despite an overall decline of intra- and inter-state conflict
since the end of the cold war, approximately one third of
the world’s population currently lives in about 30 countries considered affected by conflict and fragility, mostly in
Africa, in the Middle East, Western and East Asia. Since
2012, an increasing intensity of internal conflict is associated with the volatile situations in North Africa and the
Middle East [376–379].
These countries are often characterized by situations
where the state or institutions lack the capacity, accountability, or legitimacy to carry out basic governance
functions, including to deliver services, especially to the
poor, and to mediate relations between communities and
between citizens and the state [376–380].
Conflict affected and fragile countries present some of
the greatest development challenges of our times. Conflict limits development prospects, as demonstrated by
the fact that conflict affected low-income countries are
furthest away from achieving the Millennium Development Goals and many belong to the group of the least
developed countries [376]. Conflict threatens development gains, causes human rights violations, population
displacement, the breakdown of institutions, of essential
services, and of the infrastructure. Importantly, at times
of conflict the trust between citizens and the State and
among social groups often breaks, undermining the very
pillars of a society [380].
Conflict also has macro-level impacts. These include a
decline in state capacity associated with a shrinking revenue
base and reduced public spending, and economic stagnation as a result of a fall in exports, hyper-inflation, exchange
rate depreciation, disinvestment, and capital flight.
Recent changes in conflicts have introduced additional
layers of complexity. Most contemporary conflicts are of
protracted duration and/or recurrent, intra-state, fought
by irregular armed groups, are fuelled by economic opportunities and ethnic rivalry, and are impacted upon by global illicit trades and networks. Violence increasingly takes
place in settings with higher income and in contexts of increasing urbanization. It increasingly affects civilian and
wealthier population groups [381]. These trends are further explained below.
From poor to higher income

Many conflict affected and fragile countries are lowincome. The association of low economic indicators and
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conflict is in some instances quite high. It is estimated
that the typical low-income developing country faces
around a 14 % risk of civil war in any five-year period
[382]. On the other hand, on average a country that experienced major violence over the period 1981–2005 has
a poverty rate 21 % points higher than a country that
has seen no violence [376]. The gap in poverty between
countries affected by violent conflict and others is widening and projections suggest that an increasingly number of poor people will be concentrated in the future in
conflict affected and fragile states [383]. Over half of the
Iraqi, Palestinian and Sudanese population, for example,
is estimated to be living in poverty or extreme poverty,
compared to a 20–25 % regional average. This is gradually changing. Beginning with the Balkan and Caucasus
wars in the 1990s, many conflicts now take place in settings with higher incomes and life expectancies. In
addition, a variety of conflict settings may be present in
a single country (e.g. Soudan, Democratic Republic of
Congo) [381].
Conflict is recurrent and changes over time

Conflicts are not a one-time event; they are on-going
and repeated. Re-occurrence of violence in contexts that
have already experienced a conflict is high, with an estimated 50 % of relapse into conflict in the first postconflict decade [376, 384]. In addition, conflict changes
over time and different forms of violence interact with
each other and with internal and external stresses, including environmental and other global factors (e.g.
illicit traffics such as arms, drugs). In recent times conflict diffusion and conflict escalation in countries and
regions previously considered relatively stable and with
good performance across a range of governance and
socio-economic indicators (e.g. Middle East and North
Africa) creates a new set of challenges [378].
Conflict goes beyond borders

The consequences of conflict, including its economic
impact, are not confined to a country. Neighboring
countries and regions are affected by spillovers, including
increased insecurity and criminal activity, population displacement (e.g. nearly 75 % of world’s refugees are hosted
by neighboring countries), stress on local services, and
losses from deteriorating regional trade, among others. A
country making development advances, like Tanzania, for
example, loses an estimated 0.7 % of GDP every year for
each neighbor in conflict [376].
Conflict is costly and drains resources

The impact of conflict on the national, regional and global
economy is high. The global economic impact of containing violence was estimated to be US$9.46 trillion in 2012
or 11 % of Gross World Product and nearly double the
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value of the world’s agricultural production. The total global
expenditure for health was estimated to be 6.5 trillion in
2012. The cost the typical civil war is estimated at least $50
billion, or equivalent to more than 30 years of GDP growth
for a medium-size developing country [384, 385]. If the
world were to reduce its expenditure on violence by 50 % it
could fund the additional amount required to achieve the
Millennium Development Goals (e.g., $60bn) [379].
Conflict and environmental degradation

In regards to the linkages between conflict, climate change,
and environmental degradation, whilst there is some evidence that environmental stress can increase the severity
and duration of conflict, research suggests that the empirical foundation for a general causal relationship between
climate change, environmental degradation and armed
conflict is indicative [386–388]. Countries that are characterized by other conflict-promoting features are plausible
candidates for climate-induced conflict. In the long term,
this may change as climate change may increase risk of
conflict through environmental displacement and heightened competition for resources.
Conflict trap

The interaction between the causes and consequences of
conflict, including weak governance, low levels of human
development, stagnant economies, high poverty rate, and
various forms of inequality and exclusion push countries
in a vicious cycle of violence, fragility, and economic
decline, a conflict trap, from which it is very difficult to
escape [382].
Taking into account the trends here highlighted, the
next section explores potential linkages between conflict
and asthma.
Linkages between conflict and asthma

The limited availability of accurate socio-economic data,
including on asthma prevalence, in most conflict affected and fragile countries, particularly in low income
ones, does not allow identifying a clear and direct correlation between conflict and asthma. High death rate
due to asthma recorded in a number of low-income
conflict affected and fragile countries in Africa are
likely related more to a lack of access to health services,
low life expectancy, and an overall high mortality rate
than to any particular impact of asthma [389]. General
trends in asthma prevalence and some of the common
triggers of asthma also do not suggest a clear and direct
link between asthma and conflict.
Recent changes in conflicts characteristics, mentioned
earlier, however, are profoundly changing the demographics
and disease burden of conflict-affected populations. These
combined with trends in asthma characteristics (e.g., rising
prevalence in low and middle income countries, with
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documented disparities related to social and economic
status, and a marked increase in Africa in recent years)
may suggest a potential for greater interaction in the
future [159, 381].
Current knowledge suggests the following potential indirect links between conflict and asthma.
Conflict, vulnerability, poverty, and asthma

Conflict, poverty, and vulnerability are closely associated.
During conflict, key social indicators typically fall and a
cycle of degradation and human vulnerability is set in
motion [390]. Vulnerable population and individuals, including poor people, and in particular children and
women, are disproportionally impacted. These groups
experience a sudden and long lasting worsening of their
living conditions, more acute poverty (e.g., due to loss of
assets, income and access to markets, and as social service spending falls), greater exposure to hazards, including health hazards, and to various forms of deprivation,
and increased levels of stress. To the extent that asthma
may be more concentrated among people of lower
socio-economic status given their higher exposure to
suboptimal, unhealthy environmental conditions (e.g.
physical, social, and psychological conditions) it may be
that poor and vulnerable people in conflict situations
may be more exposed to asthma or may see their capacity
to access preventive and curative measures dramatically
reduced [159].
Conflict, stress and asthma

Depression, trauma and emotional distress are common
consequences of conflict and are much higher among
war-affected populations than the general population.
Between 30–70 % of people who have lived in war zones
suffer from symptoms of post-traumatic stress disorder
and depression [391]. These conditions can have an impact on people’s vulnerability to asthma as psychological
factors are recognized to have a role by generating, precipitating or exacerbating asthma and by affecting a patient’s asthma control [159].
Conflict, population movements, and asthma

The displacement of people is a major social and economic consequence of conflict, in the short term as well
as in post-conflict periods. By end 2012, 45.2 million
people were forcibly displaced worldwide. Reflecting an
increase in intra-state conflict, data shows an increasing
number of internally displaced persons (i.e., some 28.8
million) and a decreasing refugee population (some 15.4
million) [392]. An increasing number of displaced people
seek refuge in urban environments rather than in refugee
camps, where they often live informally alongside residents and economic migrants, forming a type of mixed
migration (e.g., Iraqis in Syria and Jordan, and Zimbabweans
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in South Africa) [381]. Conflict induced migration, including from rural to urban centers, displacement to densely
populated areas (e.g., refugee camps), and migration to third
countries may create conditions that increase people’s
vulnerability, including vulnerability to asthma. Linkages
between conflict induced migration and asthma may be
direct, e.g. migration from rural to urban areas or from
one country to another may involve exposure to a new set
of pollutants and allergens as well as changes in housing
conditions, diet and accessibility to medical services which
may affect migrants’ health [159]. They may be indirect,
for instance where migration worsens overall living conditions and reduces access to health services including in
the receiving areas and population. In addition displacements of people have a high impact on receiving communities, institutions, and services, which may result in a
worsening of socio-economic and environmental conditions for an even greater number of people.
Taking into account the potential linkages here
highlighted, the next section explores the relation between conflict, health service delivery, and the treatment of asthma more in detail.
Conflict, health services and asthma

Conflict is associated with poor service-related outcomes,
including health outcomes. As delivery systems suffer, and
there is a decline in quality, provision, and access, people’s
health deteriorates, and a whole range of health needs becomes unattended. The impact of conflict on health and
of failed health systems is often immediately visible in increased morbidity, mortality and disability [390, 393].
In most conflict affected and fragile situations - particularly in low-income ones – the common conditions that
enable the State to deliver public services and people
ability to access them are in many instances already
weak before the conflict started. These include sound
governance practices, effective central policy framework,
adequate budgets, technical skills, capacity for planning,
data collection, and coordination, security, and socioeconomic and political conditions. Service delivery is often
available only in urban areas, in certain regions within a
country, and/or to some population groups. Often they
are already overstretched addressing primary, survivaloriented health needs, and endemic diseases.
During and just after a conflict capacities and budgets
of key service providers are further eroded, or diverted
to other urgent priorities, skilled health professionals are
dramatically reduced, treatments become unavailable,
and systems may break down completely or become a
target of conflicting parties, particularly in remote rural
areas. The health sector poses particular challenges for
service delivery at times of conflict, as health services
are often highly transaction-intensive, difficult to monitor, and depend on determinants that lie outside the
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sector (e.g., water/sanitation, the mother’s education,
nutrition) [390].
Populations affected by conflict experience severe public
health consequences due to insecurity, poverty, vulnerability, displacement or issues of trust in and legitimacy of service providers that may prevent people from accessing
services altogether. Poor and vulnerable people, whose use
of and/or access to health care interventions is already lower
than among richer groups, are particularly affected [394].
Based on this evidence, it is highly unlikely that in
conflict affected situations diseases like asthma, which
entail substantive education, awareness and monetary
costs would receive due consideration and that capacity
and resources would be available for diagnosis and
treatment, even if the prevalence were to be high [159].
Furthermore, conflict and its consequences would likely
increase most barriers to reducing the burden of asthma,
including poverty and inadequate resources, low public
health priority for asthma compared to other diseases,
poor health care infrastructure, a tendency for care to be
acute rather than long-term, difficulties in implementing
guidelines developed in wealthier countries, limited availability of, and access to, medication due to cost and distribution problems, and lack of patient education, under-use
of self-management and use of unproven therapies.
Things may change. As the profile of conflict-affected
countries and populations changes, so does the burden
of disease. Health policies and interventions will have to
be revised. Whilst infectious diseases, pneumonia, neonatal disorders and endemic diarrhea are likely to continue to cause substantial mortality and morbidity in
underserviced, insecure regions of sub-Saharan Africa
and Asia and in conflict settings with low-income and
low life expectancy, overcrowding- related epidemics
(e.g., cholera, measles) might be arising less frequently
than previously as less conflict affected populations are
likely to live in camp settings. Non-infectious chronic
diseases are becoming increasingly prominent in conflict
settings because of improved recognition of their importance, possible increases in their prevalence in some
long-term conflict affected areas, and because conflicts
in middle-income countries, and increasingly in urban
settings, affects different population groups [381].
Conclusions

Violent conflict has multiple, long- and short-term impacts
on physical, economic and social capital, development, and
human well-being. The consequences of conflict are felt at
various spatial levels, within the immediate area of conflict,
in neighboring countries, and globally.
Current trends suggest a change in characteristics, patterns, and concentration of conflict with a shift towards
intra-state conflict, middle-income countries, and urban
environments. The spread of violence to countries with
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relatively good socio-economic indicators in the Middle
East and North Africa is likely to further change the patterns of conflict and it consequences.
Available data and research suggest that, although no
solid and direct link can be established between conflict
and asthma, some potential indirect relations could be
explored. These relate to the linkages between conflict,
poverty and vulnerability, population displacement, conflictinduced stress, and asthma prevalence and trends.
The specific impact of conflict on health outcomes
and access to health services is widely documented and
has potentially a significant impact on availability of, and
access to, diagnostic and treatment services for asthma.
Given the changing patterns of conflict, also the dynamics
between conflict and health and the provision of health
services, including for asthma, are likely to change.
These trends, and trends in asthma prevalence, suggest
a potential for increased interaction between conflict
and asthma and the need to better understand the linkages between the two, which could be further explored
in future research.

Economical aspects of climate change
Asthma is a very common and increasingly widespread
disease, in both western and developing countries, with
significant health care costs that include direct costs, related to outflows during the disease period, and indirect
costs, derived from missing work/school days and decreased productivity [395]. In the United States in 2009
the total costs attributed to asthma was about $20 billion
dollars per year [396]. Moreover, the economic impact of
asthma is higher in patients with more severe disease, and
in patients with severe persistent disease a poor control
is associated with higher costs (more than double)
[397–399]. Indeed, asthma exacerbations have a demonstrated significant impact on health care and asthmarelated costs [400]. In Europe, a recent population-based
study in adults patients with persistent asthma from 11
European countries showed that the mean total cost per
patient was EUR 1.583, ranging from EUR 509 in patients
with controlled asthma to EUR 2.281 in patients with
uncontrolled disease, and was largely driven by indirect
costs; the expected total cost in the population aged
30–54 years of the 11 European countries was EUR 4.3
billion (EUR 19.3 billion when extended to the whole
European population aged from 15 to 64 years) [401].
The economic impact of climate changes are just beginning to be understood. In the evaluation of climate
change consequences, health costs have rarely been included, causing thereby substantial underestimation of
related costs. Only few studies have assessed the future
health costs associated to climate change [402, 403].
An important study evaluated the health-related costs
from each type of extreme events that is recognized to

Page 41 of 52

be increasing as a consequence of changing climate:
ozone pollution, heat waves, hurricanes, infectious disease outbreaks, river flooding, and wildfires. The authors
used economic methods and state-collected or published
data on the numbers of deaths, hospitalizations and
emergency room visits to calculate the health cost of
these six climate change-related events, that struck the
United States of America between 2000 and 2009, and
that resulted in 1689 early deaths, 8992 hospitalizations,
21,113 emergency department visits and 734,398 outpatient visits, and the total cost from all the six events.
They found an estimated total cost that was more than
$14 billion US dollars, with 95 % due to the value of
lives lost prematurely [404].
In 2011 The Union of Concerned Scientists, a nonprofit partnership of scientists and citizens aimed at
achieving practical environmental solutions in the
United States of America, published a document in
which the health care costs associated with ozone pollution, as a result of climate change, were estimated to be
approximately $2.7 billion and $5.4 billion US dollars for
an increase of ozone levels of 1 ppb and 2 ppb, respectively [405]. Regarding asthma, the health care costs of climate change are due to an increase in the number of
patients and to an increase in disease severity.
Given that increases in temperature from climate change
may increase ground-level ozone as well as aeroallergen
concentrations, the interactions between these two airway
noxious agents are very important [406]. Moreover, the
close relationship between pollution, as a result of human
activities, and global warming is now clearly demonstrated,
and in patients with allergic and respiratory diseases
the exposure to pollutants and the global warming act
in a synergistic way in worsening the disease [407]. Specifically, ground-level concentration of ozone (O3), a
potent oxidant, is likely to be related to climate change
because it increases proportionally to the temperature
[408]. Animal models and studies in humans have
shown that ozone worsens bronchial inflammation associated with increased oxidative stress, and airway responsiveness; in asthmatic patients this results in acute respiratory
symptoms and reduced lung function [409, 410]. Thus, the
exposures to ground-level O3 is associated with emergency
visits and hospitalizations for asthma and worse asthma
control [410, 412].
It is reasonable to think that the negative impact of climate change on respiratory diseases results in an increase
in costs for these diseases. The direct biological effect of
pollutants and heat waves on respiratory system, the effect
on allergenic plants and pollen distribution and also the
fact that an increasing proportion of the population lives
in urban areas, where is more exposed to pollutants, result
in an increased incidence and a more severe asthma.
These, as reported above, are associated with an increase
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of health care and asthma-related costs related to direct
costs (hospital admission, emergency visits, physician
visits, diagnostics and medication) and indirect costs
(work absenteeism, school days lost, disability) [397–401].
At global level, this increased costs due to worsening of
asthma have not yet been clearly defined.
An important research conducted in Southern California
(Riverside and Long Beach) evaluated the economic impact
of the air pollution-related burden of asthma in an area
where O3 levels increased from 29 to 57 ppb between 1996
and 2004 [413]. The authors estimated the indirect and direct costs due to asthma-exacerbations linked with pollution
and the costs of health care for asthma cases attributable to
traffic-related pollution exposure. They concluded that the
total additional asthma-specific cost each year that is due to
air pollution was $18 million US dollars.
Regarding European Union (EU) countries, Bartlett
et al., evaluated the economic impact of environment
attributable childhood health outcome. The authors used
a cost-of-illness approach to assess health care costs and
the environment attributable fraction modeling to assess
the percentage of diseases due to environmental exposure,
focusing on costs in 27 EU members in the year 2008.
Considering asthma, they concluded that environmental
attributable costs of children suffering from asthma in
European Union was $1.6 billion [414].
Cost-of-illness studies provide a measure of the potential economic burden of a disease, estimating the amount
that could be saved or gained if the disease is eradicated
[415]. For asthma and allergic diseases, preliminary prediction of cost-of-illness indicates that direct and indirect
costs will significantly rise. Bielory et al., developed a simple Babesyan/supply chain economic model in order to
draw parallels between climate changes and allergic diseases and asthma. Preliminary data showed a potential
30 % rise within the next decade in medical costs for
allergic diseases and asthma as climate change impact
continue to rise at the same rate [416].
Health adaptation costs, now defined as the costs of
taking measures to reduce or to cope with additional impacts arising as a result of climate change, are of comparable importance. Adaptation measures in response to
actual or expected climatic stimuli or their effects have
in fact significant costs. These measures comprise all actions taken to reduce, prevent, or treat these additional
cases of disease or death, including actions outside the
health sector. Health adaptation costs include: costs of
improving or modifying health protection systems (like
vector surveillance systems or aeroallergen monitoring
and forecasting), costs of introducing novel health interventions (heat-wave or other broader early warning systems), additional costs for meeting environmental and
health regulatory standards (air quality and water quality,
urban/settlement planning, building design and heating,
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ventilating and air-conditioning), costs of improving or
modifying health systems infrastructure, occupational
health costs (measures to prevent the adverse impacts
on productivity of workers), costs of health research on
reducing the impact of climate change (education, research) [188].
In 2007 the United Nation Framework Convention on
Climate Change (UNFCCC) has estimated a cost of $4–12
billion/year in 2030 for adaptation in the health sector in
order to prevent additional cases of common diseases due
to climate change in developing countries [401, 417]. The
World Bank (2010) estimates an average annual adaptation costs in the health sector for diarrhea and malaria
prevention and treatment around $2 billion over the
40- year period 2010–50 [418]. More recently, UNFCCC
has estimated that $73 billion US dollars per year will
be needed for adaptation measures by 2030, including
$5 billion spent directly by the health sector and over
$25 billion by sectors influencing public health, such
as water supply and sanitation [419].
Also for asthma, adaptation costs will be needed in order
to reduce the impact on allergic people (e.g. aeroallergen
monitoring, aeroallergen forecasting, allergenic plant management, planting practices and policies, urban/settlement
planning, building design and heating, air-conditioning)
[189] measures for preserving biodiversity. The balance between the cost of undertaking such measures of adaptation
and the economic benefit that would result by reducing the
impact on asthma and allergic diseases must be established.

Final conclusion
Climate change affects the social and environmental determinants of health – clean air, safe drinking water, sufficient food, and secure shelter. The direct damage costs
to health by the WHO is estimated to be between US$
2–4 billion per year by the year 2030. Asthma is a heterogeneous disease that is strongly influenced by environmental factors. Many of these factors are influenced
by meteorological events and climate change that vary in
type and intensity across the world. To our knowledge
there has been no systematic appraisal of how these different factors, which are related to weather and climate
conditions, produce their varied effects on this disease,
or the future influence of global climate change on environmental exposures.
Observational evidence indicates that recent regional
changes in climate, particularly increases in temperature,
have already affected a diverse set of physical and biological
systems in many parts of the world. A rapid increase has
been observed in the number of hot days and severe meteorological events witnessed across the globe. The overall
topic of the effects of meteorological conditions on asthma
is of global scope; this document addresses the range of
these conditions and their effects, regionally and nationally.
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As the World Allergy Organization is focused on increasing
awareness of the rising prevalence of asthma and allergic
diseases worldwide as a global public health concern, this
paper presents information on various meteorological aspects. This document aims to fill the knowledge gap in the
form of a comprehensive overview of the available evidence.
We have chosen those fields where meteorological or related influences are greatest. Areas with weak health infrastructure – mostly low and middle income regions – will
be the least able to cope with this. Research to understand
the impact of these factors of climate change on asthma
and allergic diseases, and strategies and policies to reduce
emissions of greenhouse gases and air pollution, are crucial.
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